WO2015094714A1 - Proteases in grain processing - Google Patents

Proteases in grain processing Download PDF

Info

Publication number
WO2015094714A1
WO2015094714A1 PCT/US2014/068763 US2014068763W WO2015094714A1 WO 2015094714 A1 WO2015094714 A1 WO 2015094714A1 US 2014068763 W US2014068763 W US 2014068763W WO 2015094714 A1 WO2015094714 A1 WO 2015094714A1
Authority
WO
WIPO (PCT)
Prior art keywords
protease
slurry
enzyme
fermentation
starch
Prior art date
Application number
PCT/US2014/068763
Other languages
French (fr)
Inventor
Collette Michelle BLAKE
Regina Chin
Xiaogang Gu
Vivek Sharma
Paula Johanna Maria Teunissen
Original Assignee
Danisco Us Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc. filed Critical Danisco Us Inc.
Publication of WO2015094714A1 publication Critical patent/WO2015094714A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • C12P7/08Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
    • C12P7/10Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P2203/00Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Abstract

The present invention relates to reducing the viscosity of grain slurry and reduction in foaming during liquefaction and/or fermentation using proteases. The invention also relates to increasing the rate and/or yield of fermentation products, including ethanol from grains.

Description

PROTEASES IN GRAIN PROCESSING CROSS REFERENCE TO RELATED APPLICATIONS
[001] This application claims benefit of priority from the International application Serial No. PCT/CN 13/89939 filed 19 December 2013 and is incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
[002] The commercial viability of producing ethanol as a fuel source from agricultural crops has generated renewed worldwide interest due to a variety of reasons that include continued and increased dependence on limited oil supplies and the fact that ethanol production is a renewable energy source.
[003] Alcohol fermentation production processes and particularly ethanol production processes are generally characterized as wet milling or dry milling processes. Reference is made to Bothast et al., 2005,Appl. Microbiol. Biotechnol. 67: 19-25 and THE ALCOHOL
TEXTBOOK, 5th Ed, W.M. Ingledew et al. Eds, 2009, Nottingham University Press, UK for a review of these processes.
[004] Wet milling process involves a series of soaking (steeping) steps to soften the cereal grain wherein soluble starch is removed followed by recovery of the germ, fiber (bran) and gluten (protein). The remaining starch is further processed by drying, chemical and/or enzyme treatments. The starch may then be used for alcohol production, high fructose corn syrup or commercial pure grade starch or other fermentration products.
[005] Dry grain milling involves a number of basic steps, which include: grinding, cooking, liquefaction, saccharification, fermentation and separation of liquid and solids to produce alcohol and other co-products. Generally, whole cereal, such as corn cereal, is ground to a fine particle size and then mixed with liquid in a slurry tank. The slurry is subjected to high temperatures in a jet cooker along with liquefying enzymes (e.g. alpha-amylases) to solubilize and hydrolyze the starch in the cereal to dextrins. The mixture is cooled down and further treated with saccharifying enzymes (e.g. glucoamylases) to produce fermentable glucose. The mash containing glucose is then fermented for approximately 24 to 120 hours in the presence of ethanol producing microorganisms. The solids in the mash are separated from the liquid phase and ethanol and useful co-products such as distillers' grains are obtained.
[006] Improvements to the above fermentation processes have been accomplished by combining the saccharification step and fermentation step in a process referred to as
simultaneous saccharification and fermentation or simultaneous saccharification, yeast propagation and fermentation. These improved fermentation processes have advantages over the previously described dry or wet milling fermentation processes because significant sugar concentrations do not develop in the fermenter thereby avoiding sugar inhibition of yeast growth. In addition, bacterial growth is reduced due to lack of easily available glucose.
Increased ethanol production may result by use of the simultaneous saccharification and fermentation processes.
[007] Wheat is a primary feedstock for grain processing in many parts of the world for the production of fuel alcohol and starch. Wheat grain is similar to other grains in total proximate composition but differs in processing characteristics. Wheat processing in the dry grind process suffers with higher viscosity during liquefaction due to the presence of glucans and
arabinoxylans. Other similar grains include, but are not limited to, triticale, barley, rye, etc. Due to the high viscosity, processing plants may need to add other enzymes and use lower solids concentrations to avoid processing problems.
[008] Wheat processing also suffers with high amount of foaming characteristic during the fermentation process for fuel alcohol. Perhaps, the reduced amount of oil in wheat and presence of specific soluble proteins lead to high amounts of surface foaming during fermentation. To combat the foaming problems, plant owners may add anti-foaming chemicals. In addition, fermentation tanks are only partially filled to compensate for the extra head space that the foam may take up.
[009] The corn kernel has two kinds of endosperm portion: hard and soft endosperm. The soft endosperm contains spherical starch granule in protein matrix. The hard endosperm contains polygonal starch granules packed in a highly complex protein matrix. During drying on the cob and in the storage bins the protein matrix in hard endosperm are stretched and tightly aligned with starch granules which themselves change shapes from nice spherical shapes to polygonal shapes due to stretching during drying. Adding a protease to break the protein structure may result in release of more starch to be available for enzymes and yeast.
[0010] The present invention relates to, among other things, use of proteases that may help reduce the viscosity during liquefaction and the foaming characteristic during fermentation of wheat processing. Also the proteases may enhance the grains' ethanol fermentation yields and/or rates.
SUMMARY OF THE INVENTION
[0011] The invention relates to use of proteases during the process of conversion of starch containing material, e.g., wheat, corn or other similar grains, to fermentation products, such as alcohol, providing benefits such as (1) reducing the foaming characteristics of the grain slurry during liquifaction and fermentation and (2) reducing the viscosity during liquefaction unit operation and 3) enhancing the rate and/or yield of the fermentation. These and other benefits may result in processing of higher solids content in mash; higher solids in final syrup; better heat transfer, improved energy efficiencies; improved evaporation of thin stillage, reduced evaporator fouling, etc.
[0012] In one aspect, the invention comprises a method for producing a fermentation product from grain, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product.
[0013] In another aspect, the invention comprises a method for increasing the yield and/or rate of ethanol production from grain, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce ethanol, wherein the yield and/or rate of ethanol production is greater than the rate observed witout the addition of protease.
[0014] In another aspect, the invention comprises a method for reducing the viscosity of the grain slurry during a fermentation, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product, wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 40% or 50%.
[0015] In another aspect, the invention comprises a method for reducing the foam in the grain slurry during a fermentation, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product; wherein the foam in the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the foam is reduced by 30%, 40%, or 50%. [0016] In another aspect, the invention comprises a method for reducing the viscosity of the grain slurry during a liquefaction process, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 40% or 50%.
[0017] In another aspect, the invention comprises a method for reducing the foam in the grain slurry during a liquefaction process, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using: an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; wherein the foam in the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the foam is reduced by 30%, 40%, or 50%.
[0018] In another aspect, the invention comprises a method for reducing the viscosity of the grain slurry during a liquefaction process, comprising: liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 90°C using: an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 40% or 50%.
[0019] In another aspect of the invention, the protease is a metallopro tease. In another aspect of the invention, the protease is AruProl. In another aspect of the invention, the protease is PspPro2. In another aspect of the invention, the protease is SliPro2. In another aspect of the invention, the protease is SumPro2. In another aspect of the invention, the protease is PspPro3. In another aspect of the invention, the protease is PehProl. In another aspect of the invention, the protease is SruProl. In another aspect of the invention, the protease is SumProl. In another aspect of the invention, the protease is PhuProl. In another aspect of the invention, the protease is FERMGEN. In another aspect of the invention more than one proteases are used. Some of these proteases are disclosed in various patent applications, for example, pending Chinese patent applications, CN13/076369, CN13/076419, CN13/076386, CN13/076387, CN13/076390, CN13/076401, CN13/076383, CN13/076406, CN13/076414, CN13/076384, CN13/076398, CN 13/076415, all of which are filed on 29 May 2013 all of which are herein incorporated by reference in their entirety.
DETAILED DESCRIPTION
[0020] The invention relates to use of proteases during the process of conversion of starch containing material, e.g., wheat or other similar grains, to fermentation products, such as alcohol, providing benefits such as (1) reducing the foaming characteristics of the grain slurry during liquifaction and fermentation and (2) reducing the viscosity during liquefaction unit operation and 3) enhancing the rate and/or yield of the fermentation. These and other benefits may result in processing of higher solids content in mash; higher solids in final syrup; better heat transfer, improved energy efficiencies; improved evaporation of thin stillage, reduced evaporator fouling, etc.
[0021] Prior to describing the various aspects and embodiments of the present compositions and methods, the following definitions and abbreviations are described. 1. Definitions and Abbreviations
[0022] In accordance with this detailed description, the following abbreviations and definitions apply. Note that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an enzyme" includes a plurality of such enzymes, and reference to "the dosage" includes reference to one or more dosages and equivalents thereof known to those skilled in the art, and so forth.
[0023] The present document is organized into a number of sections for ease of reading; however, the reader will appreciate that statements made in one section may apply to other sections. In this manner, the headings used for different sections of the disclosure should not be construed as limiting.
[0024] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The following terms are provided below.
1.1. Abbreviations and Acronyms
[0025] The following abbreviations/acronyms have the following meanings unless otherwise specified: ABTS: 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid ; AE or AEO: alcohol ethoxylate; AES or AEOS: alcohol ethoxysulfate; AkAA: Aspergillus kawachii a-amylase; AnGA : Aspergillus niger glucoamylase; AOS: a-olefinsulfonate; AS: alkyl sulfate; cDNA: complementary DNA; CMC: carboxymethylcellulose; DE: dextrose equivalent; DNA:
deoxyribonucleic acid; DPn: degree of saccharide polymerization having n subunits; ds or DS: dry solids; DTMPA: diethylenetriaminepentaacetic acid; EC: Enzyme Commission; EDTA: ethylenediaminetetraacetic acid; EO: ethylene oxide (polymer fragment); EOF: End of
Fermentation; GA: glucoamylase; GAU/g ds: glucoamylase activity unit/gram dry solids;
HFCS: high fructose corn syrup; HgGA: Humicola grisea glucoamylase; IPTG: isopropyl β-D- thiogalactoside; IRS: insoluble residual starch; kDa: kiloDalton; LAS: linear
alkylbenzenesulfonate; LAT, BLA: B. licheniformis amylase; MW: molecular weight; MWU:
modified Wohlgemuth unit; 1.6xl0~5 mg/MWU = unit of activity; NCBI: National Center for Biotechnology Information; NOBS: nonanoyloxybenzenesulfonate; NTA: nitriloacetic acid; OxAm: Purastar HP AM 5000L (Danisco US Inc.); PAHBAH : p-hydroxybenzoic acid hydrazide; PEG: polyethyleneglycol; pi: isoelectric point; PI: performance index; ppm: parts per million, e.g., μg protein per gram dry solid ; PVA: poly(vinyl alcohol); PVP:
poly(vinylpyrrolidone); RCF: relative centrifugal/centripetal force {i.e., x gravity); RNA:
ribonucleic acid; SAS: alkanesulfonate; SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis; SSF: simultaneous saccharification and fermentation ; SSU/g solid : soluble starch unit/gram dry solids; sp.: species; TAED: tetraacetylethylenediamine; Tm: melting temperature; TrGA : Trichoderma reesei glucoamylase; w/v: weight/volume; w/w:
weight/weight; v/v: volume/volume; wt : weight percent; °C: degrees Centigrade; H20: water; dH20 or DI: deionized water; dIH20: deionized water, Milli-Q filtration; g or gm: grams; μg: micrograms; mg: milligrams; kg: kilograms;
Figure imgf000007_0001
and μΐ: microliters; mL and ml: milliliters; mm: millimeters; μιη: micrometer; M: molar; mM: millimolar; μΜ: micromolar; U: units; sec:
seconds; min(s): minute/minutes; hr(s): hour/hours; DO: dissolved oxygen; Ncm: Newton centimeter; ETOH: ethanol; eq.: equivalents; N: normal; MWCO: molecular weight cut-off; SSRL: Stanford Synchrotron Radiation Lightsource; PDB: Protein Database; CAZy:
Carbohydrate-Active Enzymes database; Tris-HCl: tris(hydroxymethyl)aminomethane hydrochloride; HEPES: 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; mS/cm: milli- Siemens/cm; CV: column volumes.
1.2. Definitions
[0026] As used herein, the terms "protease" and "proteinase" refer to an enzyme protein that has the ability to break down other proteins. A protease has the ability to conduct "proteolysis," which begins protein catabolism by hydrolysis of peptide bonds that link amino acids together in a peptide or polypeptide chain forming the protein. This activity of a protease as a protein-digesting enzyme is referred to as "proteolytic activity." Many procedures exist for measuring proteolytic activity {See e.g., Kalisz, "Microbial Proteinases," In: Fiechter (ed.), Advances in Biochemical Engineering/Biotechnology. (1988)). For example, proteolytic activity may be ascertained by comparative assays which analyze the respective protease' s ability to hydrolyze a commercially available substrate. Exemplary substrates useful in the analysis of protease or proteolytic activity, include, but are not limited to, di-methyl casein (Sigma C-9801), bovine collagen (Sigma C-9879), bovine elastin (Sigma E-1625), and bovine keratin (ICN Biomedical 902111). Colorimetric assays utilizing these substrates are well known in the art {See e.g., WO 99/34011 and U.S. Pat. No. 6,376,450, both of which are incorporated herein by reference). The pNA assay (See e.g., Del Mar et al, Anal. Biochem. 99:316-320 [1979]) also finds use in determining the active enzyme concentration for fractions collected during gradient elution. This assay measures the rate at which p-nitroaniline is released as the enzyme hydrolyzes the soluble synthetic substrate, succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA) or AGLA- pNA. The rate of production of yellow color from the hydrolysis reaction is measured at 410 nm on a spectrophotometer and is proportional to the active enzyme concentration. In addition, absorbance measurements at 280 nanometers (nm) can be used to determine the total protein concentration. The active enzyme/total protein ratio gives the enzyme purity.
[0100] Metalloproteases (MPs) are among the hydrolases that mediate nucleophilic attack on peptide bonds using a water molecule coordinated in the active site. In their case, a divalent ion, such as zinc, activates the water molecule. This metal ion is held in place by amino acid ligands, usually 3 in number. The clan MA consists of zinc-dependent MPs in which two of the zinc ligands are the histidines in the motif: HisGluXXHis. This Glu is the catalytic residue. These are two domain proteases with the active site between the domains. In subclan MA(E), also known as Glu-zincins, the 3 rd ligand is a Glu located C-terminal to the HDXXH motif. Members of the families: Ml, 3, 4, 13, 27 and 34 are all secreted proteases, almost exclusively from bacteria (Rawlings and Salvessen (2013) Handbook of Proteolytic Enzymes, Elsevier Press). They are generally active at elevated temperatures and this stability is attributed to calcium binding.
Thermolysin-like proteases are found in the M4 family as defined by MEROPS (Rawlings et al., (2012) Nucleic Acids Res 40:D343-D350).
[0101] The terms "amylase" or "amylolytic enzyme" refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch, a-amylases are hydrolases that cleave the a-D-(l→4) O-glycosidic linkages in starch. Generally, a-amylases (EC 3.2.1.1; a-D-(l→4)- glucan glucanohydrolase) are defined as endo-acting enzymes cleaving a-D-(l→4) O-glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-a-linked D-glucose units. In contrast, the exo-acting amylolytic enzymes, such as β-amylases (EC 3.2.1.2; a-D-(l→4)-glucan maltohydrolase) and some product- specific amylases like maltogenic a-amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate, β-amylases, a-glucosidases (EC 3.2.1.20; a-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; a-D-(l→4)-glucan glucohydrolase), and product- specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specific maltooligosaccharides. [0027] "Enzyme units" herein refer to the amount of product formed per time under the specified conditions of the assay. For example, a "glucoamylase activity unit" (GAU) is defined as the amount of enzyme that produces 1 g of glucose per hour from soluble starch substrate (4% DS) at 60°C, pH 4.2. A "soluble starch unit" (SSU) is the amount of enzyme that produces 1 mg of glucose per minute from soluble starch substrate (4% DS) at pH 4.0, 50°C. DS refers to "dry solids."
[0028] The term "starch" refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin with the formula (C6H1oOs)x, wherein X can be any number. The term includes plant-based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, corn, rye, rice, sorghum, brans, cassava, millet, milo, potato, sweet potato, and tapioca. The term "starch" includes granular starch. The term "granular starch" refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to gelatinization.
[0029] The terms, "wild-type," "parental," or "reference," with respect to a polypeptide, refer to a naturally- occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more amino acid positions. Similarly, the terms "wild-type," "parental," or "reference," with respect to a polynucleotide, refer to a naturally-occurring polynucleotide that does not include a man-made nucleoside change. However, note that a polynucleotide encoding a wild-type, parental, or reference polypeptide is not limited to a naturally-occurring polynucleotide, and encompasses any polynucleotide encoding the wild- type, parental, or reference polypeptide.
[0030] Reference to the wild-type polypeptide is understood to include the mature form of the polypeptide. A "mature" polypeptide or variant, thereof, is one in which a signal or a pro- sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
[0031] The term "variant," with respect to a polypeptide, refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid.
Similarly, the term "variant," with respect to a polynucleotide, refers to a polynucleotide that differs in nucleotide sequence from a specified wild-type, parental, or reference polynucleotide. The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
[0032] In the case of the present a-amylases, "activity" refers to a-amylase activity, which can be measured as described, herein. [0033] The term "recombinant," when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state. Thus, for example, recombinant cells express genes that are not found within the native (non-recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature. Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g. , a heterologous promoter in an expression vector. Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences. A vector comprising a nucleic acid encoding an amylase is a recombinant vector.
[0034] The terms "recovered," "isolated," and "separated," refer to a compound, protein (polypeptides), cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature. An "isolated" polypeptides, thereof, includes, but is not limited to, a culture broth containing secreted polypeptide expressed in a heterologous host cell.
[0035] The term "purified" refers to material (e.g., an isolated polypeptide or
polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
[0036] The term "enriched" refers to material (e.g. , an isolated polypeptide or
polynucleotide) that is in about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.
[0037] The terms "thermostable" and "thermostability," with reference to an enzyme, refer to the ability of the enzyme to retain activity after exposure to an elevated temperature. The thermostability of an enzyme, such as an amylase enzyme, is measured by its half-life (t^) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions. The half-life may be calculated by measuring residual a- amylase activity following exposure to (i.e. , challenge by) an elevated temperature.
[0038] A "pH range," with reference to an enzyme, refers to the range of pH values under which the enzyme exhibits catalytic activity.
[0039] The terms "pH stable" and "pH stability," with reference to an enzyme, relate to the ability of the enzyme to retain activity over a wide range of pH values for a predetermined period of time (e.g. , 15 min., 30 min., 1 hour).
[0040] The term "amino acid sequence" is synonymous with the terms "polypeptide," "protein," and "peptide," and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an "enzyme." The conventional one-letter or three- letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino-to-carboxy terminal orientation (i.e., N→C).
[0041] The term "nucleic acid" encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids may be single stranded or double stranded, and may be chemical modifications. The terms "nucleic acid" and "polynucleotide" are used interchangeably. Because the genetic code is degenerate, more than one codon may be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation.
[0042] "Hybridization" refers to the process by which one strand of nucleic acid forms a duplex with, i.e., base pairs with, a complementary strand, as occurs during blot hybridization techniques and PCR techniques. Stringent hybridization conditions are exemplified by hybridization under the following conditions: 65°C and 0.1X SSC (where IX SSC = 0.15 M NaCl, 0.015 M Na3 citrate, pH 7.0). Hybridized, duplex nucleic acids are characterized by a melting temperature (Tm), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleotides within the duplex lower the Tm.
[0043] A "synthetic" molecule is produced by in vitro chemical or enzymatic synthesis rather than by an organism.
[0044] The terms "transformed," "stably transformed," and "transgenic," used with reference to a cell means that the cell contains a non-native (e.g., heterologous) nucleic acid sequence integrated into its genome or carried as an episome that is maintained through multiple generations. The non-native sequence may be endogenous seqeunce.
[0045] The term "introduced" in the context of inserting a nucleic acid sequence into a cell, means "transfection", "transformation" or "transduction," as known in the art.
[0046] A "host strain" or "host cell" is an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced. Exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) capable of expressing the polypeptide of interest and/or fermenting saccharides. The term "host cell" includes protoplasts created from cells.
[0047] The term "heterologous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.
[0048] The term "endogenous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally in the host cell. [0049] The term "expression" refers to the process by which a polypeptide is produced based on a nucleic acid sequence. The process includes both transcription and translation.
[0050] A "selective marker" or "selectable marker" refers to a gene capable of being expressed in a host to facilitate selection of host cells carrying the gene. Examples of selectable markers include but are not limited to antimicrobials (e.g. , hygromycin, bleomycin, or chloramphenicol) and/or genes that confer a metabolic advantage, such as a nutritional advantage on the host cell.
[0051] A "vector" refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types. Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes and the like.
[0052] An "expression vector" refers to a DNA construct comprising a DNA sequence encoding a polypeptide of interest, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host. Such control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
[0053] The term "operably linked" means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner. For example, a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequences.
[0054] A "signal sequence" is a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell. The mature form of an extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.
[0055] "Biologically active" refer to a sequence having a specified biological activity, such an enzymatic activity.
[0056] The term "specific activity" refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
[0057] As used herein, "water hardness" is a measure of the minerals (e.g. , calcium and magnesium) present in water.
[0058] As used herein, an "effective amount of amylase," or similar expressions, refers to an amount of amylase sufficient to produce a visible, or otherwise measurable amount of starch hydrolysis in an particular application. Starch hydrolysis may result in, e.g., a visible cleaning of fabrics or dishware, reduced viscosity of a starch slurry or mash, and the like. [0059] A "swatch" is a piece of material such as a fabric that has a stain applied thereto. The material can be, for example, fabrics made of cotton, polyester or mixtures of natural and synthetic fibers. The swatch can further be paper, such as filter paper or nitrocellulose, or a piece of a hard material such as ceramic, metal, or glass. For amylases, the stain is starch based, but can include blood, milk, ink, grass, tea, wine, spinach, gravy, chocolate, egg, cheese, clay, pigment, oil, or mixtures of these compounds.
[0060] A "smaller swatch" is a section of the swatch that has been cut with a single hole punch device, or has been cut with a custom manufactured 96-hole punch device, where the pattern of the multi-hole punch is matched to standard 96-well microtiter plates, or the section has been otherwise removed from the swatch. The swatch can be of textile, paper, metal, or other suitable material. The smaller swatch can have the stain affixed either before or after it is placed into the well of a 24-, 48- or 96-well microtiter plate. The smaller swatch can also be made by applying a stain to a small piece of material. For example, the smaller swatch can be a stained piece of fabric 5/8" or 0.25" in diameter. The custom manufactured punch is designed in such a manner that it delivers 96 swatches simultaneously to all wells of a 96-well plate. The device allows delivery of more than one swatch per well by simply loading the same 96-well plate multiple times. Multi-hole punch devices can be conceived of to deliver simultaneously swatches to any format plate, including but not limited to 24-well, 48-well, and 96-well plates. In another conceivable method, the soiled test platform can be a bead made of metal, plastic, glass, ceramic, or another suitable material that is coated with the soil substrate. The one or more coated beads are then placed into wells of 96-, 48-, or 24-well plates or larger formats, containing suitable buffer and enzyme.
[0061] "A cultured cell material comprising an amylase" or similar language, refers to a cell lysate or supernatant (including media) that includes an amylase as a component. The cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
[0062] "Percent sequence identity" means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the CLUSTAL W algorithm are:
Gap opening penalty: 10.0
Gap extension penalty: 0.05
Protein weight matrix: BLOSUM
DNA weight matrix: IUB
Delay divergent sequences %: 40
Gap separation distance: 8 DNA transitions weight: 0.50
List hydrophilic residues: GPSNDQEKR
Use negative matrix: OFF
Toggle Residue specific penalties: ON
Toggle hydrophilic penalties: ON
Toggle end gap separation penalty OFF.
[0063] Deletions are counted as non-identical residues, compared to a reference sequence.
Deletions occurring at either termini are included. For example, a variant 500-amino acid residue polypeptide with a deletion of five amino acid residues from the C-terminus would have a percent sequence identity of 99% (495/500 identical residues x 100) relative to the parent polypeptide. Such a variant would be encompassed by the language, "a variant having at least
99% sequence identity to the parent."
[0064] "Fused" polypeptide sequences are connected, i.e. , operably linked, via a peptide bond between two subject polypeptide sequences.
[0065] The term "filamentous fungi" refers to all filamentous forms of the subdivision Eumycotina, particularly Pezizomycotina species.
[0066] The term "degree of polymerization" (DP) refers to the number (n) of anhydro- glucopyranose units in a given saccharide. Examples of DPI are the monosaccharides glucose and fructose. Examples of DP2 are the disaccharides maltose and sucrose. The term "DE," or "dextrose equivalent," is defined as the percentage of reducing sugar, i.e., D-glucose, as a fraction of total carbohydrate in a syrup.
[0067] The term "dry solids content" (ds) refers to the total solids of a slurry in a dry weight percent basis. The term "slurry" refers to an aqueous mixture containing insoluble solids.
[0068] The phrase "simultaneous saccharification and fermentation (SSF)" refers to a process in the production of biochemicals in which a microbial organism, such as an
ethanologenic microorganism, and at least one enzyme, such as an amylase, are present during the same process step. SSF includes the contemporaneous hydrolysis of starch substrates (granular, liquefied, or solubilized) to saccharides, including glucose, and the fermentation of the saccharides into alcohol or other biochemical or biomaterial in the same reactor vessel.
[0069] An "ethanologenic or fermenting microorganism" refers to a microorganism with the ability to convert a sugar or oligosaccharide to ethanol.
[0070] The term "fermented beverage" refers to any beverage produced by a method comprising a fermentation process, such as a microbial fermentation, e.g., a bacterial and/or fungal fermentation. "Beer" is an example of such a fermented beverage, and the term "beer" is meant to comprise any fermented wort produced by fermentation/brewing of a starch-containing plant material. Often, beer is produced exclusively from malt or adjunct, or any combination of malt and adjunct.
[0071] The term "malt" refers to any malted cereal grain, such as malted barley or wheat.
[0072] The term "adjunct" refers to any starch and/or sugar containing plant material that is not malt, such as barley or wheat malt. Examples of adjuncts include common corn grits, refined corn grits, brewer's milled yeast, rice, sorghum, refined corn starch, barley, barley starch, dehusked barley, wheat, wheat starch, torrified cereal, cereal flakes, rye, oats, potato, tapioca, cassava and syrups, such as corn syrup, sugar cane syrup, inverted sugar syrup, barley and/or wheat syrups, and the like.
[0073] The term "mash" refers to an aqueous slurry of any starch and/or sugar containing plant material, such as grist, e.g., comprising crushed barley malt, crushed barley, and/or other adjunct or a combination thereof, mixed with water later to be separated into wort and spent grains.
[0074] The term "wort" refers to the unfermented liquor run-off following extracting the grist during mashing.
[0075] "Iodine-positive starch" or "IPS" refers to (1) amylose that is not hydrolyzed after liquefaction and saccharification, or (2) a retrograded starch polymer. When saccharified starch or saccharide liquor is tested with iodine, the high DPn amylose or the retrograded starch polymer binds iodine and produces a characteristic blue color. The saccharide liquor is thus termed "iodine-positive saccharide," "blue saccharide," or "blue sac."
[0076] The terms "retrograded starch" or "starch retro gradation" refer to changes that occur spontaneously in a starch paste or gel on ageing.
[0077] The terms "wheat" and "wheat-like" refer to various grains that contain higher amounts of glucans and arabinoxylans, then majority starch-containing grains such as corn and rice.
[0078] The term "about" refers to + 15% to the referenced value.
2. Enzymes of the Invention
Proteases
[0079] Proteases are currently classified into six broad groups: Serine proteases, Threonine proteases, Cysteine proteases, Aspartate proteases, Glutamic proteases, and metallopro teases. The mechanism used to cleave a peptide bond involves making an amino acid residue that has the cysteine and threonine ( the cysteine and threonine proteases) or a water molecule (aspartic acid, metallo- and glutamic acid proteases) nucleophilic so that it can attack the peptide carboxyl group. One way to make a nucleophile is by a catalytic triad, where a histidine residue is used to activate serine, cysteine, or threonine as a nucleophile.
[0080] Proteases of the invention may be wild type proteases or a variant thereof. Any suitable protease may be adapted to perform in the methods of the invention. [0081] In another aspect of the invention, the protease is a metallopro tease. In another aspect of the invention, the protease is AruProl. In another aspect of the invention, the protease is PspPro2. In another aspect of the invention, the protease is SliPro2. In another aspect of the invention, the protease is SumPro2. In another aspect of the invention, the protease is PspPro3. In another aspect of the invention, the protease is PehProl. In another aspect of the invention, the protease is SruProl. In another aspect of the invention, the protease is SumProl. In another aspect of the invention, the protease is PhuProl. In another aspect of the invention, the protease is FERMGEN. In another aspect of the invention more than one proteases are used. Some of these proteases are disclosed in various patent applications, for example, pending Chinese patent applications, CN13/076369, CN13/076419, CN13/076386, CN13/076387, CN13/076390, CN13/076401, CN13/076383, CN13/076406, CN13/076414, CN13/076384, CN13/076398, CN13/076415, all of which are filed on 29 May 2013 all of which are herein incorporated by reference in their entirety.
[0082] In some embodiments, the present enzymes have a defined degree of amino acid sequence identity to other enzymes, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity. In some embodiments, the present enzymes are derived from a parental enzyme having a defined degree of amino acid sequence identity, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity.
[0083] In some embodiments, the present enzymes comprise conservative substitution of one or several amino acid residues relative to the amino acid sequence of a parent enzyme.
Exemplary conservative amino acid substitutions are listed in the Table below Some
conservative mutations can be produced by genetic manpulation, while others are produced by introducing synthetic amino acids into a polypeptide other means. Table 1. Conservative amino acid substitutions
For Amino Acid Code Replace with any of
Alanine A D-Ala, Gly, beta- Ala, L-Cys, D-Cys
Arginine R D-Arg, Lys, D-Lys, homo-Arg, D-homo-Arg, Met, He,
D-Met, D-Ile, Orn, D-Orn
Asparagine N D-Asn, Asp, D-Asp, Glu, D-Glu, Gin, D-Gln
Figure imgf000017_0001
[0084] In some embodiments, the present enzymes comprises a deletion, substitution, insertion, or addition of one or a few amino acid residues. In some embodiments, the present enzymes are derived from the amino acid sequence of the parent enzyme by conservative substitution of one or several amino acid residues. In some embodiments, the present enzymes are derived from the amino acid sequence of the parent enzyme by deletion, substitution, insertion, or addition of one or a few amino acid residues. In all cases, the expression "one or a few amino acid residues" refers to 10 or less, i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acid residues.
[0085] In some embodiments, the present enzymes are encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid sequence that is complementary to a nucleic acid that encodes the parent enzyme.
[0086] The present enzymes may be "precursor," "immature," or "full-length," in which case they include a signal sequence, or "mature," in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective amylase polypeptides. The present amylase polypeptides may also be truncated to remove the N or C- termini, so long as the resulting polypeptides retain enzyme activity. [0087] The present enzyme may be a "chimeric" or "hybrid" polypeptide, in that it includes at least a portion of a first enzyme polypeptide, and at least a portion of a second enzyme polypeptide (such chimeric enzymes have recently been "rediscovered" as domain-swap enzymes). The present enzymes may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like. Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
[0088] In another aspect, nucleic acids encoding an enzyme polypeptide is provided. The nucleic acid may encode the enzyme having the amino acid sequence having a specified degree of amino acid sequence identity. In some embodiments, the nucleic acid encodes an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to any of SEQ ID NOs: 1-17. In some embodiments, the nucleic acid has at least 80%, at least 85%, at least 90%, at least 95%, or even at least 98% nucleotide sequence identity to parental enzyme.
[0089] In some embodiments, the present compositions and methods include nucleic acids that encode an enzyme having deletions, insertions, or substitutions, such as those mentioned, above. It will be appreciated that due to the degeneracy of the genetic code, a plurality of nucleic acids may encode the same polypeptide.
[0090] In another example, the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid encoding an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to a parent enzyme. In some embodiments, the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid having the sequence of a parent enzyme. Such hybridization conditions are described herein but are also well known in the art.
[0091] Nucleic acids may encode a "full-length" ("fl" or "FL") amylase, which includes a signal sequence, only the mature form of an enzyme, which lacks the signal sequence, or a truncated form of an enzyme, which lacks the N or C-terminus of the mature form. Preferrably, the nucleic acids are of sufficient length to encode an active enzyme.
[0092] A nucleic acid that encodes an enzyme can be operably linked to various promoters and regulators in a vector suitable for expressing the enzyme in host cells. Exemplary promoters are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA. Such a nucleic acid can also be linked to other coding sequences, e.g., to encode a chimeric polypeptide.
3. Production of Enzymes of the Invention [0093] The present enzymes can be produced in host cells, for example, by secretion or intracellular expression. A cultured cell material {e.g., a whole-cell broth) comprising an enzyme can be obtained following secretion of the enzyme into the cell medium. Optionally, the enzyme can be isolated from the host cells, or even isolated from the cell broth, depending on the desired purity of the final enzyme. A gene encoding an enzyme can be cloned and expressed according to methods well known in the art. Suitable host cells include bacterial, fungal
(including yeast and filamentous fungi), and plant cells (including algae). Particularly useful host cells include Aspergillus niger, Aspergillus oryzae or Trichoderma reesei. Other host cells include bacterial cells, e.g., Bacillus subtilis or B. licheniformis, as well as Streptomyces.
[0094] The host cell further may express a nucleic acid encoding a homologous or heterologous glucoamylase, i.e., a glucoamylase that is not the same species as the host cell, or one or more other enzymes. The glucoamylase may be a variant glucoamylase, such as one of the glucoamylase variants disclosed in U.S. Patent No. 8,058,033 (Danisco US Inc.), for example. Additionally, the host may express one or more accessory enzymes, proteins, peptides. These may benefit liquefaction, saccharification, fermentation, SSF, etc processes. Furthermore, the host cell may produce biochemicals in addition to enzymes used to digest the various feedstock(s). Such host cells may be useful for fermentation or simultaneous saccharification and fermentation processes to reduce or eliminate the need to add enzymes.
3.1. Vectors
[0095] A DNA construct comprising a nucleic acid encoding an enzyme can be constructed to be expressed in a host cell. Because of the well-known degeneracy in the genetic code, different polynucleotides that encode an identical amino acid sequence can be designed and made with routine skill. It is also well-known in the art to optimize codon use for a particular host cell. Nucleic acids encoding enzymes can be incorporated into a vector. Vectors can be transferred to a host cell using well-known transformation techniques, such as those disclosed below.
[0096] The vector may be any vector that can be transformed into and replicated within a host cell. For example, a vector comprising a nucleic acid encoding an enzyme can be transformed and replicated in a bacterial host cell as a means of propagating and amplifying the vector. The vector also may be transformed into an expression host, so that the encoding nucleic acids can be expressed as a functional enzyme. Host cells that serve as expression hosts can include filamentous fungi, for example. The Fungal Genetics Stock Center (FGSC) Catalogue of Strains lists suitable vectors for expression in fungal host cells. See FGSC, Catalogue of Strains, University of Missouri, at www.fgsc.net (last modified January 17, 2007). A
representative vector is pJG153, a promoterless Cre expression vector that can be replicated in a bacterial host. See Harrison et al. (2011) Applied Environ. Microbiol. 77:3916-22. pJG153can be modified with routine skill to comprise and express a nucleic acid encoding an enzyme variant.
[0097] A nucleic acid encoding an enzyme can be operably linked to a suitable promoter, which allows transcription in the host cell. The promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell. Exemplary promoters for directing the transcription of the DNA sequence encoding an enzyme, especially in a bacterial host, are the promoter of the lac operon of E. coli, the Streptomyces coelicolor agarase gene dagA or celA promoters, the promoters of the Bacillus licheniformis a-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens a-amylase (amyQ), the promoters of the Bacillus subtilis xylA and xylB genes etc. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral a-amylase, A. niger acid stable a-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase, or A. nidulans acetamidase. When a gene encoding an enzyme is expressed in a bacterial species such as E. coli, a suitable promoter can be selected, for example, from a bacteriophage promoter including a T7 promoter and a phage lambda promoter. Examples of suitable promoters for the expression in a yeast species include but are not limited to the Gal 1 and Gal 10 promoters of Saccharomyces cerevisiae and the Pichia pastoris AOX1 or AOX2 promoters, cbhl is an endogenous, inducible promoter from T. reesei. See Liu et al. (2008) "Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization," Acta Biochim. Biophys. Sin (Shanghai) 40(2): 158-65.
[0098] The coding sequence can be operably linked to a signal sequence. The DNA encoding the signal sequence may be the DNA sequence naturally associated with the enzyme gene to be expressed or from a different Genus or species. A signal sequence and a promoter sequence comprising a DNA construct or vector can be introduced into a fungal host cell and can be derived from the same source. For example, the signal sequence is the cbhl signal sequence that is operably linked to a cbhl promoter.
[0099] An expression vector may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably linked to the DNA sequence encoding an enzyme. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
[00100] The vector may further comprise a DNA sequence enabling the vector to replicate in the host cell. Examples of such sequences are the origins of replication of plasmids pUC19, pACYClW, pUBl lO, pE194, pAMBl, and pLJ702.
[00101] The vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B.
licheniformis, or a gene that confers antibiotic resistance such as, e.g., ampicillin, kanamycin, chloramphenicol or tetracycline resistance. Furthermore, the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and xxsC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, such as known in the art. See e.g., International PCT Application WO 91/17243.
[00102] Intracellular expression may be advantageous in some respects, e.g., when using certain bacteria or fungi as host cells to produce large amounts of enzyme for subsequent enrichment or purification. Extracellular secretion of enzyme into the culture medium can also be used to make a cultured cell material comprising the isolated enzyme.
[00103] The expression vector typically includes the components of a cloning vector, such as, for example, an element that permits autonomous replication of the vector in the selected host organism and one or more phenotypically detectable markers for selection purposes. The expression vector normally comprises control nucleotide sequences such as a promoter, operator, ribosome binding site, translation initiation signal and optionally, a repressor gene or one or more activator genes. Additionally, the expression vector may comprise a sequence coding for an amino acid sequence capable of targeting the enzyme to a host cell organelle such as a peroxisome, or to a particular host cell compartment. Such a targeting sequence includes but is not limited to the sequence, SKL. For expression under the direction of control sequences, the nucleic acid sequence of the enzyme is operably linked to the control sequences in proper manner with respect to expression.
[00104] The procedures used to ligate the DNA construct encoding an enzyme, the promoter, terminator and other elements, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to persons skilled in the art (see, e.g., Sambrook et al, MOLECULAR CLONING: A LABORATORY MANUAL, 2nd ed., Cold Spring Harbor, 1989, and 3rd ed., 2001).
3.2. Transformation and Culture of Host Cells
[00105] An isolated cell, either comprising a DNA construct or an expression vector, is advantageously used as a host cell in the recombinant production of an enzyme. The cell may be transformed with the DNA construct encoding the enzyme, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage, as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination.
Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
[00106] Examples of suitable bacterial host organisms are Gram positive bacterial species such as Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus lautus, Bacillus megaterium, and Bacillus thuringiensis; Streptomyces species such as Streptomyces murinus; lactic acid bacterial species including Lactococcus sp. such as Lactococcus lactis; Lactobacillus sp. including Lactobacillus reuteri; Leuconostoc sp.; Pediococcus sp.; and Streptococcus sp. Alternatively, strains of a Gram negative bacterial species belonging to Enterobacteriaceae including E. coli, or to Pseudomonadaceae can be selected as the host organism.
[00107] A suitable yeast host organism can be selected from the biotechnologically relevant yeasts species such as but not limited to yeast species such as Pichia sp., Hansenula sp., or Kluyveromyces, Yarrowinia, Schizosaccharomyces species or a species of Saccharomyces, including Saccharomyces cerevisiae or a species belonging to Schizosaccharomyces such as, for example, S. pombe species. A strain of the methylotrophic yeast species, Pichia pastoris, can be used as the host organism. Alternatively, the host organism can be a Hansenula species.
Suitable host organisms among filamentous fungi include species of Aspergillus, e.g.,
Aspergillus niger, Aspergillus oryzae, Aspergillus tubigensis, Aspergillus awamori, or
Aspergillus nidulans. Alternatively, strains of a Fusarium species, e.g., Fusarium oxysporum or of a Rhizomucor species such as Rhizomucor miehei can be used as the host organism. Other suitable strains include Thermomyces and Mucor species. In addition, Trichoderma sp., such as T. reesei can be used as a host. A suitable procedure for transformation of Aspergillus host cells includes, for example, that described in EP 238023. An enzyme expressed by a fungal host cell can be glycosylated, i.e., will comprise a glycosyl moiety. The glycosylation pattern can be the same or different as present in the wild-type enzyme. The type and/or degree of glycosylation may impart changes in enzymatic and/or biochemical properties.
[00108] It may be advantageous to delete genes from expression hosts, where the gene deficiency may be cured by the transformed expression vector. Known methods may be used to obtain a fungal host cell having one or more inactivated genes. Gene inactivation may be accomplished by complete or partial deletion, by insertional inactivation or by any other means that renders a gene nonfunctional for its intended purpose, such that the gene is prevented from expression of a functional protein. Any gene from a Trichoderma sp. or other filamentous fungal host that has been cloned can be deleted, for example, cbhl, cbh2, egll, and egl2 genes. Gene deletion may be accomplished by inserting a form of the desired gene to be inactivated into a plasmid by methods known in the art.
[00109] Introduction of a DNA construct or vector into a host cell includes techniques such as transformation; electroporation; nuclear microinjection; transduction; transfection, e.g., lipofection mediated and DEAE-Dextrin mediated transfection; incubation with calcium phosphate DNA precipitate; high velocity bombardment with DNA-coated microprojectiles; and protoplast fusion. General transformation techniques are known in the art. See, e.g., Sambrook et al. (2001), supra. The expression of heterologous protein in Trichoderma is described, for example, in U.S. Patent No. 6,022,725. Reference is also made to Cao et al. (2000) Science 9:991-1001 for transformation of Aspergillus strains. Genetically stable transformants can be constructed with vector systems whereby the nucleic acid encoding an enzyme is stably integrated into a host cell chromosome. Transformants are then selected and purified by known techniques.
[00110] The preparation of Trichoderma sp. for transformation, for example, may involve the preparation of protoplasts from fungal mycelia. See Campbell et al. (1989) Curr. Genet. 16: 53- 56. The mycelia can be obtained from germinated vegetative spores. The mycelia are treated with an enzyme that digests the cell wall, resulting in protoplasts. The protoplasts are protected by the presence of an osmotic stabilizer in the suspending medium. These stabilizers include sorbitol, mannitol, potassium chloride, magnesium sulfate, and the like. Usually the
concentration of these stabilizers varies between 0.8 M and 1.2 M, e.g., a 1.2 M solution of sorbitol can be used in the suspension medium.
[00111] Uptake of DNA into the host Trichoderma sp. strain depends upon the calcium ion concentration. Generally, between about 10-50 mM CaCl2 is used in an uptake solution.
Additional suitable compounds include a buffering system, such as TE buffer (10 mM Tris, pH 7.4; 1 niM EDTA) or 10 niM MOPS, pH 6.0 and polyethylene glycol. The polyethylene glycol is believed to fuse the cell membranes, thus permitting the contents of the medium to be delivered into the cytoplasm of the Trichoderma sp. strain. This fusion frequently leaves multiple copies of the plasmid DNA integrated into the host chromosome.
[00112] Usually transformation of Trichoderma sp. uses protoplasts or cells that have been subjected to a permeability treatment, typically at a density of 10 5 to 107 /mL, particularly 2xl06/mL. A volume of 100
Figure imgf000024_0001
of these protoplasts or cells in an appropriate solution {e.g., 1.2 M sorbitol and 50 mM CaCl2) may be mixed with the desired DNA. Generally, a high concentration of PEG is added to the uptake solution. From 0.1 to 1 volume of 25% PEG 4000 can be added to the protoplast suspension; however, it is useful to add about 0.25 volumes to the protoplast suspension. Additives, such as dimethyl sulfoxide, heparin, spermidine, potassium chloride and the like, may also be added to the uptake solution to facilitate transformation.
Similar procedures are available for other fungal host cells. See, e.g., U.S. Patent No. 6,022,725.
3.3. Expression [00113] A method of producing an enzyme may comprise cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium.
[00114] The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of an enzyme. Suitable media and media components are available from commercial suppliers or may be prepared according to published recipes {e.g., as described in catalogues of the American Type Culture Collection).
[00115] An enzyme secreted from the host cells can be used in a whole broth preparation. In the present methods, the preparation of a spent whole fermentation broth of a recombinant microorganism can be achieved using any cultivation method known in the art resulting in the expression of an enzyme. Fermentation may, therefore, be understood as comprising shake flask cultivation, small- or large-scale fermentation (including continuous, batch, fed-batch, or solid state fermentations) in laboratory or industrial fermenters performed in a suitable medium and under conditions allowing the enzyme to be expressed or isolated. The term "spent whole fermentation broth" is defined herein as unfractionated contents of fermentation material that includes culture medium, extracellular proteins {e.g., enzymes), and cellular biomass. It is understood that the term "spent whole fermentation broth" also encompasses cellular biomass that has been lysed or permeabilized using methods well known in the art.
[00116] An enzyme secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
[00117] The polynucleotide encoding an enzyme in a vector can be operably linked to a control sequence that is capable of providing for the expression of the coding sequence by the host cell, i.e. the vector is an expression vector. The control sequences may be modified, for example by the addition of further transcriptional regulatory elements to make the level of transcription directed by the control sequences more responsive to transcriptional modulators. The control sequences may in particular comprise promoters.
[00118] Host cells may be cultured under suitable conditions that allow expression of an enzyme. Expression of the enzymes may be constitutive such that they are continually produced, or inducible, requiring a stimulus to initiate expression. In the case of inducible expression, protein production can be initiated when required by, for example, addition of an inducer substance to the culture medium, for example dexamethasone or IPTG or Sophorose. Polypeptides can also be produced recombinantly in an in vitro cell-free system, such as the TNT™ (Promega) rabbit reticulocyte system.
[00119] An expression host also can be cultured in the appropriate medium for the host, under aerobic conditions. Shaking or a combination of agitation and aeration can be provided, with production occurring at the appropriate temperature for that host, e.g., from about 25°C to about 75°C {e.g., 30°C to 45°C), depending on the needs of the host and production of the desired enzyme. Culturing can occur from about 12 to about 100 hours or greater (and any hour value there between, e.g., from 24 to 72 hours). Typically, the culture broth is at a pH of about 4.0 to about 8.0, again depending on the culture conditions needed for the host relative to production of an enzyme. 3.4. Identification of Enzyme Activity
[00120] To evaluate the expression of an enzyme in a host cell, assays can measure the expressed protein, corresponding mRNA, or enzyme activity. For example, suitable assays include Northern blotting, reverse transcriptase polymerase chain reaction, and in situ hybridization, using an appropriately labeled hybridizing probe. Suitable assays also include measuring enzyme activity in a sample, for example, by assays directly measuring products in the culture media. For example, glucose concentration may be determined using glucose reagent kit No. 15-UV (Sigma Chemical Co.) or an instrument, such as Technicon Autoanalyzer.
a- Amylase activity also may be measured by any known method, such as the PAHBAH or ABTS assays, described below. Assays are also known in the art to measure other enzyme activities.
3.5. Methods for Enriching and Purifying Enzymes of the Invention
[00121] Fermentation, separation, and concentration techniques are well known in the art and conventional methods can be used in order to prepare a concentrated enzyme polypeptide- containing solution.
[00122] After fermentation, a fermentation broth is obtained, the microbial cells and various suspended solids, including residual raw fermentation materials, are removed by conventional separation techniques in order to obtain an enzyme solution. Filtration, centrifugation, microfiltration, rotary vacuum drum filtration, ultrafiltration, centrifugation followed by ultrafiltration, extraction, or chromatography, or the like, are generally used.
[00123] It is desirable to concentrate an enzyme polypeptide-containing solution in order to optimize recovery. Use of unconcentrated solutions requires increased incubation time in order to collect the enriched or purified enzyme precipitate.
[00124] The enzyme containing solution is concentrated using conventional concentration techniques until the desired enzyme level is obtained. Concentration of the enzyme containing solution may be achieved by any of the techniques discussed herein. Exemplary methods of enrichment and purification include but are not limited to rotary vacuum filtration and/or ultrafiltration.
[00125] The enzyme solution is concentrated into a concentrated enzyme solution until the enzyme activity of the concentrated enzyme polypeptide-containing solution is at a desired level.
[00126] During fermentation, an enzyme polypeptide accumulates in the culture broth. For the isolation, enrichment, or purification of the desired enzyme, the culture broth is centrifuged or filtered to eliminate cells, and the resulting cell-free liquid is used for enzyme enrichment or purification. In one embodiment, the cell-free broth is subjected to salting out using ammonium sulfate at about 70% saturation; the 70% saturation-precipitation fraction is then dissolved in a buffer and applied to a column such as a Sephadex G-100 column, and eluted to recover the enzyme-active fraction. For further enrichment or purification, a conventional procedure such as ion exchange chromatography may be used.
[00127] For production scale recovery, enzyme polypeptides can be enriched or partially purified as generally described above by removing cells via flocculation with polymers.
Alternatively, the enzyme can be enriched or purified by microfiltration followed by
concentration by ultrafiltration using available membranes and equipment. However, for some applications, the enzyme does not need to be enriched or purified, and whole broth culture can be lysed and used without further treatment. The enzyme can then be processed, for example, into granules.
4. Compositions and Uses of Enzymes of the Invention
[00128] The present enzymes find use any many applications. For example, proteases and a- amylases are useful in a starch conversion process, particularly in a saccharification process of a starch that has undergone liquefaction. The desired end-product may be any product that may be produced by the enzymatic conversion of the starch substrate. For example, the desired product may be a syrup rich in glucose and maltose, which can be used in other processes, such as the preparation of HFCS, or which can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g. , gluconate; 2-keto-L-gulonic acid; 5-keto-gluconate; and 2,5- diketo gluconate); 1,3-propanediol; aromatic amino acids (e.g. , tyrosine, phenylalanine and tryptophan); organic acids (e.g. , lactate, pyruvate, succinate, isocitrate, gluconic acid, and oxaloacetate); amino acids (e.g. , serine, lysine, glutamic acid, and glycine); antibiotics;
antimicrobials; enzymes; vitamins; and hormones.
[00129] The starch conversion process may be a precursor to, or simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e. , potable alcohol). One skilled in the art is aware of various fermentation conditions that may be used in the production of these end-products. Proteases and a-amylases are also useful in compositions and methods of food preparation. These various uses of these enzymes are described in more detail below.
4.1. Preparation of Starch Substrates
[00130] Those of general skill in the art are well aware of available methods that may be used to prepare starch substrates for use in the processes disclosed herein. For example, a useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from corn, cobs, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes. Corn contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch. Specifically contemplated starch substrates are corn starch and wheat starch. The starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs. The starch may also be highly refined raw starch or feedstock from starch refinery processes.
Various starches also are commercially available. For example, corn starch is available from Cerestar, Sigma, and Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
[00131] The starch substrate can be a crude starch from milled whole grain, which contains non- starch fractions, e.g., germ residues and fibers. Milling may comprise either wet milling or dry milling or grinding. In wet milling, whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers. Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups. In dry milling or grinding, whole kernels are ground into a fine powder and often processed without fractionating the grain into its component parts. In some cases, oils from the kernels are recovered. Dry ground grain thus will comprise significant amounts of non-starch carbohydrate compounds, in addition to starch. Dry grinding of the starch substrate can be used for production of ethanol and other biochemicals. The starch to be processed may be a highly refined starch quality, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure. 4.2. Gelatinization and Liquefaction of Starch
[00132] As used herein, the term "liquefaction" or "liquefy" means a process by which starch is converted to less viscous and shorter chain dextrins. Generally, this process involves gelatinization of starch simultaneously with or followed by the addition of an a-amylase, although additional liquefaction-inducing enzymes optionally may be added. In some embodiments, the starch substrate prepared as described above is slurried with water. The starch slurry may contain starch as a weight percent of dry solids of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%. a-Amylase (EC 3.2.1.1) may be added to the slurry, with a metering pump, for example. The a-amylase typically used for this application is a thermally stable, bacterial a-amylase, such as a Geobacillus stearothermophilus a-amylase. The α-amylase is usually supplied, for example, at about 1500 units per kg dry matter of starch. To optimize α-amylase stability and activity, the pH of the slurry typically is adjusted to about pH 5.5-6.5 and about 1 mM of calcium (about 40 ppm free calcium ions) can also be added. Geobacillus stearothermophilus variants or other a- amylases may require different conditions. Bacterial α-amylase remaining in the slurry following liquefaction may be deactivated via a number of methods, including lowering the pH in a subsequent reaction step or by removing calcium from the slurry in cases where the enzyme is dependent upon calcium.
[00133] The slurry of starch plus the α-amylase may be pumped continuously through a jet cooker, which is steam heated to 105°C. Gelatinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate. The residence time in the jet cooker is brief. The partly gelatinized starch may be passed into a series of holding tubes maintained at 105-110°C and held for 5-8 min. to complete the gelatinization process ("primary liquefaction"). Hydrolysis to the required DE is completed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours ("secondary liquefaction"). These tanks may contain baffles to discourage back mixing. As used herein, the term "minutes of secondary liquefaction" refers to the time that has elapsed from the start of secondary liquefaction to the time that the Dextrose Equivalent (DE) is measured. The slurry is then allowed to cool to room temperature. This cooling step can be 30 minutes to 180 minutes, or more. The liquefied starch typically is in the form of a slurry having a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20-40%; about 25-40%; or about 25-35%.
[00134] Liquefaction with a-amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pH 5.5-6.5. a-amylases can be used for liquefaction at a pH range of 2 to 7, e.g., pH 3.0 - 7.5, pH 4.0 - 6.0, or pH 4.5 - 5.8. a-amylases can maintain liquefying activity at a temperature range of about 85°C - 95°C, e.g., 85°C, 90°C, or 95°C. For example, liquefaction can be conducted with 800 μg an amylase in a solution of 25% DS corn starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C, for example.
Liquefying activity can be assayed using any of a number of known viscosity assays in the art.
[00135] In particular embodiments using the present α-amylases, starch liquifaction is performed at a temperature range of 90-115°C, for the purpose of producing high-purity glucose syrups, HFCS, maltodextrins, etc.
4.3. Saccharification
[00136] The liquefied starch can be saccharified into a syrup rich in lower DP (e.g., DPI + DP2) saccharides, using amylases, optionally in the presence of other enzyme(s). The exact composition of the products of saccharification depends on the combination of enzymes used, as well as the type of granular starch processed.
[00137] Whereas liquefaction is generally run as a continuous process, saccharification is often conducted as a batch process. Saccharification typically is most effective at temperatures of about 60-65°C and a pH of about 4.0-4.5, e.g., pH 4.3, necessitating cooling and adjusting the pH of the liquefied starch. Saccharification may be performed, for example, at a temperature between about 40°C, about 50°C, or about 55°C to about 60°C or about 65°C. Saccharification is normally conducted in stirred tanks, which may take several hours to fill or empty. Enzymes typically are added either at a fixed ratio to dried solids as the tanks are filled or added as a single dose at the commencement of the filling stage. A saccharification reaction to make a syrup typically is run over about 24-72 hours, for example, 24-48 hours. When a maximum or desired DE has been attained, the reaction is stopped by heating to 85°C for 5 min., for example. Further incubation will result in a lower DE, eventually to about 90 DE, as accumulated glucose re-polymerizes to isomaltose and/or other reversion products via an enzymatic reversion reaction and/or with the approach of thermodynamic equilibrium. When using an amylase,
saccharification optimally is conducted at a temperature range of about 30°C to about 75°C, e.g., 45°C - 75°C or 47°C - 74°C. The saccharifying may be conducted over a pH range of about pH 3 to about pH 7, e.g., pH 3.0 - pH 7.5, pH 3.5 - pH 5.5, pH 3.5, pH 3.8, or pH 4.5.
[00138] An amylase may be added to the slurry in the form of a composition. Amylase can be added to a slurry of a granular starch substrate in an amount of about 0.6 - 10 ppm ds, e.g., 2 ppm ds. An amylase can be added as a whole broth, clarified, enriched, partially purified, or purified enzyme. The specific activity of the amylase may be about 300 U/mg of enzyme, for example, measured with the PAHBAH assay. The amylase also can be added as a whole broth product.
[00139] An amylase may be added to the slurry as an isolated enzyme solution. For example, an amylase can be added in the form of a cultured cell material produced by host cells expressing an amylase. An amylase may also be secreted by a host cell into the reaction medium during the fermentation or SSF process, such that the enzyme is provided continuously into the reaction. The host cell producing and secreting amylase may also express an additional enzyme, such as a glucoamylase. For example, U.S. Patent No. 5,422,267 discloses the use of a glucoamylase in yeast for production of alcoholic beverages. For example, a host cell, e.g., Trichoderma reesei ox Aspergillus niger, may be engineered to co-express an amylase and a glucoamylase, e.g., HgGA, TrGA, or a TrGA variant, during saccharification. The host cell can be genetically modified so as not to express its endogenous glucoamylase and/or other enzymes, proteins or other materials. The host cell can be engineered to express a broad spectrum of various saccharolytic enzymes. For example, the recombinant yeast host cell can comprise nucleic acids encoding a glucoamylase, an alpha-glucosidase, an enzyme that utilizes pentose sugar, an a-amylase, a pullulanase, an isoamylase, and/or an isopullulanase. See, e.g., WO 2011/153516 A2. 4.4. Isomerization
[00140] The soluble starch hydrolysate produced by treatment with amylase can be converted into high fructose starch-based syrup (HFSS), such as high fructose corn syrup (HFCS). This conversion can be achieved using a glucose isomerase, particularly a glucose isomerase immobilized on a solid support. The pH is increased to about 6.0 to about 8.0, e.g., pH 7.5 (depending on the isomerase), and Ca2+ is removed by ion exchange. Suitable isomerases include SWEETZYME®, IT (Novozymes A/S); G-ZYME® IMGI, and G-ZYME® G993, KETOMAX®, G-ZYME® G993, G-ZYME® G993 liquid, and GENSWEET® IGI. Following isomerization, the mixture typically contains about 40-45% fructose, e.g., 42% fructose. 4.5. Fermentation
[00141] The soluble starch hydrolysate, particularly a glucose rich syrup, can be fermented by contacting the starch hydrolysate with a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast. The temperature and pH of the fermentation will depend upon the fermenting organism. EOF products include metabolites, such as citric acid, lactic acid, succinic acid, mono sodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, lysine and other amino acids, omega 3 fatty acid, butanol, isoprene, 1,3-propanediol and other biomaterials.
[00142] Ethanologenic microorganisms include yeast, such as Saccharomyces cerevisiae and bacteria, e.g., Zymomonas moblis, expressing alcohol dehydrogenase and pyruvate
decarboxylase. The ethanologenic microorganism can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose. Improved strains of ethanologenic microorganisms, which can withstand higher temperatures, for example, are known in the art and can be used. See Liu et al. (2011) Sheng Wu Gong Cheng Xue Bao 27: 1049-56.
Commercial sources of yeast include ETHANOL RED® (LeSaffre); THERMOSACC®
(Lallemand); RED STAR® (Red Star); FERMIOL® (DSM Specialties); and SUPERSTART® (Alltech). Microorganisms that produce other metabolites, such as citric acid and lactic acid, by fermentation are also known in the art. See, e.g., Papagianni (2007) Biotechnol. Adv. 25:244-63; John et al. (2009) Biotechnol. Adv. 27: 145-52.
[00143] The saccharification and fermentation processes may be carried out as an SSF process. Fermentation may comprise subsequent enrichment, purification, and recovery of ethanol, for example. During the fermentation, the ethanol content of the broth or "beer" may reach about 8-18% v/v, e.g., 14-15% v/v. The broth may be distilled to produce enriched, e.g., 96% pure, solutions of ethanol. Further, C02 generated by fermentation may be collected with a C02 scrubber, compressed, and marketed for other uses, e.g., carbonating beverage or dry ice production. Solid waste from the fermentation process may be used as protein-rich products, e.g., livestock feed.
[00144] As mentioned above, an SSF process can be conducted with fungal cells that express and secrete amylase continuously throughout SSF. The fungal cells expressing amylase also can be the fermenting microorganism, e.g., an ethanologenic microorganism. Ethanol production thus can be carried out using a fungal cell that expresses sufficient amylase so that less or no enzyme has to be added exogenously. The fungal host cell can be from an appropriately engineered fungal strain. Fungal host cells that express and secrete other enzymes, in addition to amylase, also can be used. Such cells may express glucoamylase and/or a pullulanase, phytase, ί /ια-glucosidase, isoamylase, beta-amylase cellulase, xylanase, other hemicellulases, protease, beta-glucosidase, pectinase, esterase, redox enzymes, transferase, or other enzyme.
[00145] A variation on this process is a "fed-batch fermentation" system, where the substrate is added in increments as the fermentation progresses. Fed-batch systems are useful when catabolite repression may inhibit the metabolism of the cells and where it is desirable to have limited amounts of substrate in the medium. The actual substrate concentration in fed-batch systems is estimated by the changes of measurable factors such as pH, dissolved oxygen and the partial pressure of waste gases, such as C02. Batch and fed-batch fermentations are common and well known in the art.
[00146] Continuous fermentation is an open system where a defined fermentation medium is added continuously to a bioreactor, and an equal amount of conditioned medium is removed simultaneously for processing. Continuous fermentation generally maintains the cultures at a constant high density where cells are primarily in log phase growth. Continuous fermentation permits modulation of cell growth and/or product concentration. For example, a limiting nutrient such as the carbon source or nitrogen source is maintained at a fixed rate and all other parameters are allowed to moderate. Because growth is maintained at a steady state, cell loss due to medium being drawn off should be balanced against the cell growth rate in the fermentation. Methods of optimizing continuous fermentation processes and maximizing the rate of product formation are well known in the art of industrial microbiology.
[00147] Proteases of the invention may be added at various stages of the above-mentioned processes. Proteases may be added with the preparation of starch substrate, during the liquefaction and/or gelatinization process, or during saccharification, isomerization or fermentation stage. Addition of proteases may improve the rate and/or yield of these processes, resulting in increased efficiencies of the overall process. 4.6. Compositions
[00148] Proteases may be combined with a glucoamylase (EC 3.2.1.3), e.g., a Trichoderma glucoamylase or variant thereof. An exemplary glucoamylase is Trichoderma reesei glucoamylase (TrGA) and variants thereof that possess superior specific activity and thermal stability. See U.S. Published Applications Nos. 2006/0094080, 2007/0004018, and 2007/0015266 (Danisco US Inc.). Suitable variants of TrGA include those with glucoamylase activity and at least 80%, at least 90%, or at least 95% sequence identity to wild-type TrGA. a- amylases advantageously increase the yield of glucose produced in a saccharification process catalyzed by TrGA.
[00149] Alternatively, the glucoamylase may be another glucoamylase derived from plants (including algae), fungi, or bacteria. For example, the glucoamylases may be Aspergillus niger Gl or G2 glucoamylase or its variants (e.g., Boel et al. (1984) EMBO J. 3: 1097-1102; WO 92/00381; WO 00/04136 (Novo Nordisk A/S)); and A awamori glucoamylase (e.g., WO 84/02921 (Cetus Corp.)). Other contemplated Aspergillus glucoamylase include variants with enhanced thermal stability, e.g., G137A and G139A (Chen et al. (1996) Prot. Eng. 9:499-505); D257E and D293E/Q (Chen et al. (1995) Prot. Eng. 8:575-582); N182 (Chen et al. (1994) Biochem. J. 301:275-281); A246C (Fierobe et al. (1996) Biochemistry, 35: 8698-8704); and variants with Pro residues in positions A435 and S436 (Li et al. (1997) Protein Eng. 10: 1199- 1204). Other contemplated glucoamylases include Talaromyces glucoamylases, in particular derived from T. emersonii (e.g., WO 99/28448 (Novo Nordisk A/S), T. leycettanus (e.g., U.S. Patent No. RE 32,153 (CPC International, Inc.)), T. duponti, or T. thermophilus (e.g., U.S.
Patent No. 4,587,215). Contemplated bacterial glucoamylases include glucoamylases from the genus Clostridium, in particular C. thermoamylolyticum (e.g., EP 135138 (CPC International, Inc.) and C. thermohydrosulfuricum (e.g., WO 86/01831 (Michigan Biotechnology Institute)). Suitable glucoamylases include the glucoamylases derived from Aspergillus oryzae, such as a glucoamylase disclosed in WO 00/04136 (Novo Nordisk A/S). Also suitable are commercial glucoamylases, such as AMG 200L; AMG 300 L; SAN™ SUPER and AMG™ E (Novozymes); OPTIDEX® 300 and OPTIDEX L-400 (Danisco US Inc.); AMIGASE™ and AMIGASE™ PLUS (DSM); G-ZYME® G900 (Enzyme Bio-Systems); and G-ZYME® G990 ZR (A. niger glucoamylase with a low protease content). Still other suitable glucoamylases include
Aspergillus fumigatus glucoamylase, Talaromyces glucoamylase, Thielavia glucoamylase, Trametes glucoamylase, Thermomyces glucoamylase, Athelia glucoamylase, or Humicola glucoamylase (e.g., HgGA). Glucoamylases typically are added in an amount of about 0.1 - 2 glucoamylase units (GAU)/g ds, e.g., about 0.16 GAU/g ds, 0.23 GAU/g ds, or 0.33 GAU/g ds. [00150] Optionally, OPTIMASH™ BG may be used which is an enzyme preparation intended for the fuel alcohol industry. This product is capable of reducing viscosity of barley and wheat mashes. OPTIMASH™ BG enzyme contains a combination of enzymes, including but not limited to, a beta glucanase and a xylanase, which effectively modify and digest non- starch carbohydrates, the structural material of plant cells. OPTIMASH™ BG is produced by submerged fermentation of a genetically modified strain of Trichoderma reesei. Alternately, or in combination, OPTIMASH™ TBG may be used, which is an enzyme blend that is heat stable, food grade preparation of the enzyme cellulase, EC 3.2.1.4. The product has been specifically formulated for use in the fermentation ethanol and starch processing industries for the breakdown of the non-starch polysaccharides of barley and wheat. It is produced by the fermentation of a non-genetically modified strain of Geosmithia emersonii, also known as Talaromyces emersonii. The major enzyme activity of OPTIMASH™ TBG enzyme is a component, endo- 1,3(4)- β-glucanase (systematic name: (I,3-l,3;l,4)-a-D-glucan 3(4)- glucanohydrolase), which catalyses the endohydrolysis of 1,3- or 1,4-linkages in B-D-giucans. [00151] Other suitable enzymes that can be used include a phytase, protease, pullulanase, β-amylase, isoamylase, a different a-amylase, alpha-glucosidase, cellulase, xylanase, other hemicellulases, beta-glucosidase, transferase, pectinase, lipase, cutinase, esterase, redox enzymes, or a combination thereof. For example, a debranching enzyme, such as an isoamylase (EC 3.2.1.68), may be added in effective amounts well known to the person skilled in the art. A pullulanase (EC 3.2.1.41), e.g., PROMOZYME®, is also suitable. Pullulanase typically is added at 100 U/kg ds. Further suitable enzymes include proteases, such as fungal and bacterial proteases. Fungal proteases include those obtained from Aspergillus, such as A. niger, A.
awamori, A. oryzae; Mucor (e.g., M. miehei); Rhizopus; and Trichoderma.
[00152] β-Amylases (EC 3.2.1.2) are exo-acting maltogenic amylases, which catalyze the hydrolysis of 1,4-a-glucosidic linkages into amylopectin and related glucose polymers, thereby releasing maltose. β-Amylases have been isolated from various plants and microorganisms. See Fogarty et al. (1979) in PROGRESS IN INDUSTRIAL MICROBIOLOGY, Vol. 15, pp. 112-115. These β-Amylases have optimum temperatures in the range from 40°C to 65°C and optimum pH in the range from about 4.0 to about 7.0. Contemplated β-amylases include, but are not limited to, β-amylases from barley SPEZYME® BBA 1500, SPEZYME® DBA, OPTIMALT™ ME, OPTIMALT™ BBA (Danisco US Inc.); and NOVOZYM™ WBA (Novozymes A/S).
[00153] Compositions comprising the present proteases may be aqueous or non-aqueous formulations, granules, powders, gels, slurries, pastes, etc., which may further comprise any one or more of the additional enzymes listed, herein, along with buffers, salts, preservatives, water, co-solvents, surfactants, and the like. Such compositions may work in combination with endogenous enzymes or other ingredients already present in a slurry, water bath, washing machine, food or drink product, etc., for example, endogenous plant (including algal) enzymes, residual enzymes from a prior processing step, and the like. EXPERIMENTAL
Example 1
Study the effect of metalloproteases on wheat foaming during fermentation
[00154] The amino acid sequences for the proteases of the invention are shown below.
[00155] The amino acid sequence of the predicted mature form of PehProl is set forth as SEQ ID NO: 1:
ATGTGKGVLGDTKSFTTTQSGSTYQLKDTTRGQGIVTYSAGNRSSLPGTLLTSSSN1WN DGAAVDAHAYTAKVYDYYKNKFGRNSIDGNGFQLKSTVHYSSRYNNAFWNGVQMV YGDGDGVTFIPFSADPDVIGHELTHGVTEHTAGLEYYGESGALNESISDIIGNAIDGKNW LIGDLIYTPNTPGD ALRSMENPKLYNQPDRYQDRYTGPSDNGGVHINSGINNKAFYLIA QGGTHYGVTVNGIGRDAAVQIFYDALINYLTPTSNFSAMRAAAIQAATDLYGANSSQV NAVKKAYTAVGVN
[0102] The amino acid sequence of the predicted mature form of PhuProl is set forth as SEQ ID NO: 2:
ATGTGKGVLGDTKSFTVGTSGSSYVMTDSTRGKGIQTYTASNRTSLPGSTVTSSSSTFN DPASVDAHAYAQKVYDFYKSNFNRNSIDGNGLAIRSTTHYSTRYNNAFWNGSQMVYG DGDGSQFIAFSGDLDVVGHELTHGVTEYTANLEYYGQSGALNESISDIFGNTIEGKNWM VGDA1YTPGVSGDALRYMDDPTKGGQPARMADYNNTSADNGGVHTNSGIPNKAYYLL AQGGTFGGVNVTGIGRSQAIQIVYRALTYYLTSTSNFSNYRSAMVQASTDLYGANSTQT T A VKNS LS A VGIN
[00156] The amino acid sequence of the SumPro2 precursor protein expressed from plasmid pGX090(aprE-SumPro2) is depicted in SEQ ID NO: 3. The predicted signal sequence is shown in italics and the inserted peptide Ala-Gly-Lys is shown in bold:
[00157] MRSKKLWISLLFALTLIFTMAFSNMSAQAAGKATATSAPASAPLGGUAGTKAD PGALPAKLSPAQRAELLSEANATKAATAKELGLGSTEKLVVRDVVQDRDGTTHTRYER TLDGLPVLGGDLVVKESAAGRTEGVSKASKATSAQLKAVGLTADVAPAAAEKQALGA AKAEGSKAEKAENAPRKVVWLGSGAPQLAYETVVGGLQHDGTPNELHVLTDATTGEK LYEWQAVHNGTGNTQYNGQVTLGTAPSYTLTDTTRGNHKTYNLNRGSSGTGTLFSGP DD1WGDGTPQNAETAGADAHYGAAETWDYYKNVHGRSGIRGDGVGAYSRVHYGNN YVNAFWQDSCFCMTYGDGSGNVKPLTSLDVAAHEMTHGLTSVTAKLVYSGESGGLNE ATSDIFAAGVEFYSNTSEDPGDYLVGEKIDINGDGTPLRYMDKPSKDGASKDYWYSGIG NVDVHYSSGPANHWFYLLSEGSGAKTVNGVNYDSPTSDGLPVTGIGRDKALQ1WFKAL TTKFTSTTNYAAARTGTLAVASELYGATSPEYAAVAHAWAGINVGARPGGGDPDPGG KVFENTTVVNIPDAGAAVTSSVTVSGVAGNAPSALKVGVDITHTWRGDLVVDLVAPD GTNYRLKNRSSGDSADNVVETYTVNASSEVANGVWKLKVQDLARQDTGRINSFKLTF
[00158] The amino acid sequence of the recombinant SumProl protein isolated from B. subtilis expression host was determined by tandem mass spectrometry ans is set forth in SEQ ID NO: 4.
[00159] GTGNSQYSGEVELTTTKSDSGFELTDGDRGGHKTYDLNQGSSGTGDLVTDD DDTWGDGTGEDRQTAAVDAHYGAAKTWDFYKTALGRDGIAGDGKAAYSRVHYGES YVNAFWDDSCFCMTYGDGEGNKNALTSIDVAAHEMTHGLTSATANLDYAGESGGLNE ATSDILGASVEFFADNASDAGDYLIGEKIDINGDGSPLRYMDQPSKDGSSADYWDENLG DIDVHYSSGVANHFFYLLAEGSGKKTINGVDYDSPTSDGSTLTGIGREKAYQIWYKALS VYMTSTTD YAGARV ATEKAATDLFGADSEELKA VS ATWTGVNVK
[00160] The amino acid sequence of the recombinant AruProl protein isolated from B. subtilis expression host was determined by tandem mass spectrometry and is set forth as SEQ ID NO: 5.
[00161] EATSGYGYGVLGDYKTLNTYYSNGTYYLYDVTKPMSGVIETRTAQNGTSLPGSYSV DSNNAWTASSQRADVDAHYYAGVVYDYYKNTHNRNSFDNNGATIRSTVHYSNRYNNAFWNG VQMVYGDGDGTTFAPLSGGLDVVAHELTHAVTDRTAGLEYRNQSGALNESMSDVFACFVDSN DYLIGEDVYTPNVSGDALRSLSNPQAYGQPAHMNDYVYTSSDNGGVHTNSGIPNKAAYLTITAI GKEKAEKIYYRALTVYLTPTSNFSNARAALLQAAADLYGSGSSTYNAVANAWNQVGVY
[00162] The amino acid sequence of the recombinant PspPro2 protein isolated from
Bacillus subtilis culture was determined by tandem mass spectrometry, and is set forth as SEQ ID NO: 6.
[00163] ATGTGRGVDGKTKSFTTTASGNRYQLKDTTRSNGIVTYTAGNRQTTPGTILT DTDNVWEDPAAVDAHAYAIKTYDYYKNKFGRDSIDGRGMQIRSTVHYGKKYNNAFW NGSQMTYGDGDGSTFTFFSGDPDVVGHELTHGVTEFTSNLEYYGESGALNEAFSDIIGN DIDGTSWLLGDGIYTPNIPGDALRSLSDPTRFGQPDHYSNFYPDPNNDDEGGVHTNSGII NKAYYLLAQGGTSHGVTVTGIGREAAVFIYYNAFTNYLTSTSNFSNARAAVIQAAKDF YGADSLAVTSAIQSFDAVGIK
[00164] The amino acid sequence of the recombinant PspPro3 protein isolated from Bacillus subtilis culture was determined by tandem mass spectrometry and is set forth as SEQ ID NO: 7.
[00165] ATGTGKGVLGDTKTFNTTASGSSYQLRDTTRGNGIVTYTASNRQSIPGTILTD ADNVWNDPAGVDAHAYAAKTYDYYKEKFNRNSIDGRGLQLRSTVHYGNRYNNAFW NGSQMTYGDGDGTTFIAFSGDPDVVGHELTHGVTEYTSNLEYYGESGALNEAFSDIIGN DIQRKNWLVGDDIYTPRIAGDALRSMSNPTLYDQPDHYSNLYRGSSDNGGVHTNSGIIN KAYYLLAQGGTFHGVTVNGIGRDAAVQIYYSAFTNYLTSSSDFSNARDAVVQAAKDLY GASSAQATAAAKSFDAVGVN
[00166] The amino acid sequence of the recombinant SruProl protein isolated from Bacillus subtilis culture was determined by tandem mass spectrometry and is set forth as SEQ ID NO: 8.
[00167] GTGKGLYSGTVTLGTYKSGTTYQLYDTARGGHKTYNLARGTSGTGTLFTDADDTW GTGTASSSSTDQTAAVDAAYGAQVTWDFYKNTFGRNGIKNNGAAAYSRVHYGSSYVNAFWSD SCFCMTYGDGSGNTHPLTSLDVAGHEMSHGVTSNTAGLNYSGESGGLNEATSDIFGTGAEFYA ANSSDAGDYLIGEKININGDGTPLRYMDKPSKDGASKDYWSAGLGSVDVHYSSGPANHFFYLL AEGSGSKTINGVSYNSPTYNGSTITGIGRAKALQIWYKALTTYFTSTTNYKAARTGTLNAASALY GSTSTEYKAVAAAWTAINVS
[00168] The SliPro2 was identified from strain Streptomyces lividans strain# 014-G3S3_sli. The gene sequence of SliPro2 was shown as SEQ ID NO: 9
[00169] GTGTCTTCCCTCTTCGCGTGCCACAAGCGCACCACTCTGGCCCTCGCCACC GCGGTCACCGCCGGAGCGATGCTCACCACCGGCCTCACCGCGGGCAACGCCGCCGC CGACAGCGCCGCGCCGTCGGCGCTTCCGGGTGCGCCCGTCCTGCTGTCGGGCAGCG CCCGCAGCGCGCTCATACAGGAGCAGCAGGCCGGCGCGGCCGGTACCGCCCGGGA GATGGGCCTCGGCGCCAAGGAGAAGCTGGTCGTCAAGGACGTGGTGAAGGACCGC GACGGCTCCGTGCAC ACCCGCTACGAGCGCACCTACGACGGCCTGCCCGTCCTCGG CGGCGACCTCGTCGTGCACCGCTCGGAGTCCGGCGCCACCAGAGGCGTCACCAAGG CGACCGAGGCCGCCGTCAAGGTGGCCACCGTCACCCCGAAGGTGAAGGCGGCCAA GGCCGAGCAGCAGGCGCTGTCCGCCGCCAAGGACGCCGGGTCGTCGAAGACCGCG GCCGACTCCGCGCCCCGCAAGGTGATCTGGGCCGCCCAGGGCAAGCCCGTGCTCGC CTACGAGACCGTGGTCGGCGGCCTCCAGGACGACGGCACCCCGAACGAACTGCACG TCATCACCGACGCCGCCACCGGCGCCAAGCTGTACGAGTACCAGGGCATCAAGACC GGCTCCGGCAAGAGCCTCTACTCGGGCACGGTCGAACTCGGCACCACCCGGTCGGG CTCGTCGTACCAGCTCTACGACACCGGACGCGGCGGCCACAAGACGTACAACCTGG CCCGCAAGACCTCCGGCACCGGCACGCTGTTCACCGACGCCGACGACACCTGGGGC ACCGGCGCCGCCTCCAGCGACCCGCAGGACCAGACCGCCGCCGTCGACGCCGCCTA CGGCGCCCAGGTCACCTGGGACTTCTACAAGGAGAGCTTCGGGCGCAGCGGCATCA AGAACGACGGCAAGGCCGCCTACTCCCGCGTCCACTACGGCAGCAACTACGTCAAC GCCTTCTGGTCGGACAGCTGCTTCTGCATGACCTACGGCGACGGCACGGGCAACAC CAACCCGCTGACCTCGCTGGACGTGGCCGGGCACGAGATGAGCCACGGCGTCACCT CCAACACCGCGGGGCTCAACTACAGCGGGGAGTCCGGCGGCCTCAACGAGGCGAC GTCGGACATCTTCGGCACCGGCGTGGAGTACTTCGCGAACAGCTCCGCCGACAAGG GCGACTACCTCATCGGCGAGCGGATCGACATCAACGGCGACGGCACCCCGCTGCGC TACATGGACGAGCCCAGCAAGGACGGCGCGTCCAAGGACTACTGGGACTCCGGTCT CGGCGGCGTCGACGTGCACTACTCGTCCGGTCCGGCCAACCACTTCTTCTTCCTGCT GTCGGAGGGCAGCGGGGCGCGGACGGTCGACGGGGTGGACTACGACTCCCCGACC TCCGACGGCTCCACGGTCACCGGCATCGGCCGCGACAAGGCCCTGCAGATCTGGTA CAAGGCGCTGACCGAGTACATGACGTCGACGACCGACTACGCGGACGCCCGCACGG CCACCCTGAGCGCGGCGTCCGACCTGTACGGCGCCGACAGCACCGAGTACAAGACG GTGGGCGCCGCCTGGACCGCGATCAACGTGAGC
[00170] The protein sequence for SliPro2 was shown as SEQ ID NO: 10 (the predicted signal peptide was shown in italic).
[00171] MSSLFACHKRTTLALATAVTAGAMLTTGLTAGNAAAOSAAPSALPGAPYLLSGS ARSALIQEQQAGAAGTAREMGLGAKEKLVVKDVVKDRDGSVHTRYERTYDGLPVLG GDLVVHRSESGATRGVTKATEAAVKVATVTPKVKAAKAEQQALSAAKDAGSSKTAA DS APRKVIWAAQGKPVLA YETVVGGLQDDGTPNELHVITD AATG AKLYEYQGIKTGSG KSLYSGTVELGTTRSGSSYQLYDTGRGGHKTYNLARKTSGTGTLFTDADDTWGTGAAS SDPQDQTAAVDAAYGAQVTWDFYKESFGRSGIKNDGKAAYSRVHYGSNYVNAFWSD SCFCMTYGDGTGNTNPLTSLDVAGHEMSHGVTSNTAGLNYSGESGGLNEATSDIFGTG VEYFANSSADKGDYLIGERIDINGDGTPLRYMDEPSKDGASKDYWDSGLGGVDVHYSS GPANHFFFLLSEGSG ARTVDGVD YDSPTSDGSTVTGIGRDKALQIWYKALTEYMTSTTD YADARTATLSAASDLYGADSTEYKTVGAAWTAINVS
[00172] The expression plasmid for SliPro2 was pGX087(AprE-SliPro2), which contains an AprE promoter, an AprE signal sequence and the synthetic gene (SEQ ID NO: 11) encoding the propeptide and mature region of SliPro2. The sequence encoding the three residue addition (AGK) is shown in bold)
[00173] GTGAGAAGCAAAAAATTGTGGATCAGCTTGTTGTTTGCGTTAACGTTAAT CTTTACGATGGCGTTCAGCAACATGAGCGCGCAGGCTGCTGGAAAAGACTCAGCA GCACCGAGCGCCCTTCCGGGAGCACCGGTTCTTCTGTCAGGCTCAGCGAGATCAGC ACTGATTCAGGAACAACAGGCGGGAGCCGCCGGAACGGCTAGAGAAATGGGCCTG GGCGCAAAAGAGAAGCTGGTCGTCAAGGACGTTGTGAAGGATAGAGACGGCAGCG TGCATACGAGATATGAGAGAACATACGACGGCCTGCCGGTCCTTGGAGGCGATCTG GTTGTCCATAGAAGCGAGTCAGGAGCCACGAGAGGCGTCACGAAGGCAACAGAGG CCGCAGTTAAAGTGGCGACAGTGACACCGAAAGTTAAGGCTGCTAAAGCAGAGCA ACAAGCCCTTTCAGCGGCTAAAGATGCAGGCAGCTCAAAAACAGCAGCCGATTCAG CGCCGAGAAAAGTTATCTGGGCAGCACAAGGCAAGCCTGTCCTGGCATATGAAACG GTTGTGGGAGGCCTGCAAGATGATGGCACGCCGAATGAACTTCATGTCATTACGGA CGCAGCGACAGGAGCTAAGCTTTACGAATACCAGGGCATCAAAACGGGATCAGGC AAGAGCCTGTACTCAGGCACGGTGGAACTGGGCACAACGAGAAGCGGCTCATCATA TCAACTGTACGACACAGGAAGAGGCGGCCATAAGACATATAACCTGGCTAGAAAA ACAAGCGGCACGGGAACGCTGTTCACAGACGCAGATGATACGTGGGGCACAGGCG CAGCGTCATCAGATCCGCAAGATCAAACGGCTGCAGTCGATGCCGCCTATGGCGCC CAAGTGACATGGGACTTCTACAAGGAGAGCTTCGGCAGAAGCGGAATCAAGAACG ATGGCAAAGCCGCATACTCAAGAGTCCATTATGGCAGCAACTATGTTAACGCCTTCT GGTCAGACAGCTGCTTTTGCATGACGTATGGCGATGGAACGGGCAATACGAATCCG CTGACATCACTGGATGTTGCTGGCCATGAGATGTCACATGGCGTTACGAGCAATAC AGCGGGACTTAACTATTCAGGCGAGAGCGGCGGACTGAACGAGGCTACGAGCGAC ATTTTTGGCACGGGCGTCGAGTATTTTGCTAATTCAAGCGCAGACAAAGGCGACTAT CTGATCGGCGAAAGAATTGACATTAACGGCGACGGCACACCGCTGAGATACATGGA TGAACCGAGC AAGGATGGCGCGTC AAAAGACTACTGGGATAGCGGCCTTGGCGGC GTGGATGTGCATTATAGCTCAGGCCCGGCAAATCATTTCTTTTTCCTGCTTTCAGAG GGCAGCGGCGCTAGAACGGTCGACGGCGTTGATTATGATTCACCGACATCAGACGG AAGCACAGTCACAGGCATTGGCAGAGATAAGGCGCTGCAAATCTGGTACAAAGCCC TGACGGAATACATGACAAGCACGACGGACTACGCTGATGCCAGAACAGCCACACTG TCAGCCGCGTCAGACCTTTATGGAGC AGACTC AACGGAGTATA AGACGGTTGGAGC GGCATGGACAGCTATCAACGTGAGC
[00174] The translation product of the synthetic AprE- SliPro2 gene is shown in SEQ ID NO: 12 (The predicted signal sequence is shown in italics, the three residue addition (AGK) is shown in bold, and the predicted pro-peptide is shown in underlined text)
[00175] MRSKKLWISLLFALTLIFTMAFSNMSAQAAGKDSAAPSALPGAPYLLSGSARSA LIOEOQAGAAGTAREMGLGAKEKLVVKDVVKDRDGSVHTRYERTYDGLPVLGGDLV VHRSESGATRGVTKATEAAVKVATVTPKVKAAKAEOQALSAAKDAGSSKTAADSAPR KVIWAAOGKPVLAYETVVGGLODDGTPNELHVITDAATGAKLYEYQGIKTGSGKSLYS GTVELGTTRSGSSYQLYDTGRGGHKTYNLARKTSGTGTLFTDADDTWGTGAASSDPQ DQTAAVDAAYGAQVTWDFYKESFGRSGIKNDGKAAYSRVHYGSNYVNAFWSDSCFC MTYGDGTGNTNPLTSLDVAGHEMSHGVTSNTAGLNYSGESGGLNEATSDIFGTGVEYF ANSSADKGDYLIGERIDINGDGTPLRYMDEPSKDGASKDYWDSGLGGVDVHYSSGPAN HFFFLLSEGSGARTVDGVDYDSPTSDGSTVTGIGRDKALQr YKALTEYMTSTTDYAD ARTATLSAASDLYGADSTEYKTVGAAWTAINVS
[00176] Effect of metalloproteases on surface foaming characteristics of wheat slurry during fermentation was studied. Wheat flour was mixed with DI water to prepare 35% ds slurry. The unadjusted pH of the slurry was at ~pH 6.0 and was left unchanged. Enzyme solutions containing SPEZYME® CL alpha amylase at 1 AAUs/g ds and OPTIMASH® TBG at
0.1kg/MT ds were dispensed in the slurry. This slurry was mixed at room temperature to blend the added enzymes. A 100 g aliquot of the prepared slurry was weighed into glass flasks. The proteases were added as such 1) no protease 2) SliPro2 at 0.05mg/g ds, 3) PehProl at 0.05mg/g ds and 4) PhuProl at 0.05mg/g ds. The flasks were incubated at 50°C for 2 hours with constant mixing. After the initial incubation the pH was adjusted to pH 4.2 using 4N sulfuric acid. ADY at 3.57 mg/g ds, urea at 600 ppm and GA at 0.8 GAUs /g ds were added to each flask. 50 g of slurry was thereafter transferred to 50 ml glass graduated cylinders for fermentation. The cylinders were incubated at room temperatures for 48 hrs. The foaming measurements were performed at 24 and 48 hrs incubation times. At 24hrs, foaming measurements were performed without disturbing the slurry. It was then subsequently mixed and the foam was monitored and measured at 1 and 1.5 hrs after mixing.
[00177] The results show that the fermentation produced foaming in the samples with no protease. But the fermentations containing metalloproteases show 60% reduced foaming. The measurements were taken with a ruler and the foaming heights are shown in table 1.
[00178] The foam measurements for the different treatments of proteases during wheat fermentations 1.5 hrs after the 24 hrs incubation mix are shown below in Tabe 2.
Table 2
Figure imgf000040_0001
[00179] A further experiment was carried out with the following conditions using human matrix metalloprotease- 1 and papain.
Enzymes and Doses:
• 2AAU/g ds SPEZYM® CL
• 0. lkg/MT ds Optimash TBG
• 0.05mg/g ds Papain
• lOug Matrix Matalloprotease-1, human
Substrate: • 35% ds Wheat Flour
• ~pH6 for liquefaction, pH4.2 for SSF
Liquefaction conditions:
• 2hrs at 60C
[00180] The amount of foam, measured in mm, was the same for all three conditions, about 40 mm indicating that papain and matrix metalloprotease- 1, human, did not exhibit foam reducing property.
Example 2
Effect of proteases on viscosity
[00181] This experiment was performed to study the effect of the metalloproteases on wheat viscosity reduction during the liquefaction unit operation in the dry grind process. Wheat flour was mixed with DI water to prepare 30% ds slurry. The pH of the slurry was adjusted to pH5.8 with IN Sulfuric Acid. The RVA program was loaded to start and incubated for 30min at 60°C followed by a temperature ramp to 85°C and incubated for another 15 min while continuously measuring the viscosity of the wheat slurry. After the RVA was heated to the starting temperature of 60°C, a 33 g wheat slurry sample was weighed in to the RVA aluminum cans and dosed with 1.0 AAUs of SPEZYME® CL and/or 0.025 kg/MT OPTIMASH® TBG and/or various dosages of Protienase T and NprE protease (table below). A double skirted paddle was placed in the can, and the can was placed in the RVA. The viscosity was continuously analyzed by the RVA over the entire 48 minute test.
Table 3. Effect of metalloprotease addition on the wheat slurry peak and final viscosities during iquef action process
Enzyme dosages Peak viscosity, cP
SPEZYME® CL at 1.0 AAUs/g ds 3448
SPEZYME® CL at 1.0 AAUs/g ds + OPTIMASH® BG at 0.025 3440
kg/MT or 0.0034 mg/g ds
SPEZYME® CL at 1.0 AAUs/g ds + SliPro2 at 0.003125 mg/g ds 3249
SPEZYME® CL at 1.0 AAUs/g ds + SliPro2at 0.00625 mg/g ds 3103
SPEZYME® CL at 1.0 AAUs/g ds + SliPro2 at 0.0125 mg/g ds 3020
SPEZYME® CL at 1.0 AAUs/g ds + SliPro2 at 0.05 mg/g ds 2632
SPEZYME® CL at 1.0 AAUs/g ds + SumProl at 0.003125 mg/g ds 3224
SPEZYME® CL at 1.0 AAUs/g ds + SumProl at 0.00625 mg/g ds 3287
SPEZYME® CL at 1.0 AAUs/g ds + SumProl at 0.0125 mg/g ds 3049
SPEZYME® CL at 1.0 AAUs/g ds + SumProl at 0.05 mg/g ds 2680
SPEZYME® CL at 1.0 AAUs/g ds + PehProl at 0.003125 mg/g ds 3422
SPEZYME® CL at 1.0 AAUs/g ds + PehProl at 0.00625 mg/g ds 2881
SPEZYME® CL at 1.0 AAUs/g ds + PehProl at 0.0125 mg/g ds 2556
SPEZYME® CL at 1.0 AAUs/g ds + PehProl at 0.05 mg/g ds 2347 Enzyme dosages Peak viscosity, cP
SPEZYME® CL at 1.0 AAUs/g ds + PhuProl at 0.00625 mg/g ds 3531
SPEZYME® CL at 1.0 AAUs/g ds + PhuProl at 0.0125 mg/g ds 2992
SPEZYME® CL at 1.0 AAUs/g ds + PhuProl at 0.05 mg/g ds 2842
Example 3
Study of the effects of addition of metallopro teases during liquefaction and/or fermentation on ethanol production in SSF.
[00182] Materials: 32% ds ground corn from ADM in Cedar Rapids, IA; Thin stillage from Lincolnway, IA (used at 30% of dilutant); IRE liquefact; Urea from JT Baker, USP grade; Yeast from Lincolnway Ethanol Red ; 6N HC1, 25 % v/v NH4OH, 6N NaOH, IN H2S04; GPA-502. Enzymes used in liquefaction and/or fermentation are shown in Table 4 below
Table 4. Enzymes used in liquefaction and/or fermentation
Figure imgf000042_0001
Experimental:
Liquefaction process - Addition of proteases
[00183] Whole corn ground slurry of 800 g at 32% ds containing 30% thin stillage was used. The slurry was then mixed well and the pH was adjusted to 5.8 using 25 % v/v NH4OH. The slurry was placed in a 70°C water bath and continuously mixed for 90 seconds. SPEZYME® CL was added into the slurry with the dosage of 0.75 AAUs/g ds. The timer was started after the enzyme was added. After the 30 minute mark, the corn slurry was taken to a 99°C water bath and continuously mixed for 10 minutes to imitate a jet cooker. The slurry was then brought back to an 85°C water bath and continuously mixed for the remainder of the experiment (160 minutes total). The secondary dosage of SPEZYME® CL at 1.0 AAUs/g ds was added at the 45 minute mark. A sample of ~1 gram was taken for DE determination at the end of 160 minute liquefaction to verify target DE of 10. This liquefaction procedure was repeated four more times under the same conditions but with proteases added in the slurry at dose of 0.007 mg/g ds in addition to the SPEZYME® CL dose. The moisture content was determined at the end of liquefaction by using a Mettler Toledo HR83 moisture balance and the amount of moisture lost for each of these cooks was calculated. The amount of water lost during liquefaction was added back in at the end using DI water and the pH was then brought back down to 4.5 using 6 N HC1.
Fermentation process - Proteases used in liquefaction
The three separate liquefacts were thawed at 60°C and then cooled to room temperature, at which point 400 ppm of urea was added to each liquefact. The pH was then adjusted to 4.5 using 6N sulfuric acid. Samples of the initial liquefacts were measured into separate 2.0 mL centrifuge tubes and centrifuged for approximately 3 minutes at 13.2k rpm. After centrifugation, the samples were prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column. For each of the five separate liquefacts, a sample of 100.00 grams (+0.05g) was weighed into 4 separate 250 mL wide-mouthed
Erlenmeyer flasks. Thus, a total of 20 flasks were used. The dose used are shown in Table 5 below.
Table 5. Dosing of fermentation enzymes
Liquefact Enzymes and dosages
SPEZYME CL TrGA + AkAA
SPEZYME CL TrGA + AkAA + 0.02 kg/MT ds FERMGEN
SPEZYME CL + AruProl 0325 GAUs/g ds TrGA + 1.950 SSUs/g ds AkAA
SPEZYME CL + AruProl TrGA + AkAA + 0.02 kg/MT ds FERMGEN
SPEZYME CL + PspPro2 0325 GAUs/g ds TrGA + 1.950 SSUs/g ds AkAA
SPEZYME CL + PspPro2 TrGA + AkAA + 0.02 kg/MT ds FERMGEN
SPEZYME CL + PspPro3 0325 GAUs/g ds TrGA + 1.950 SSUs/g ds AkAA
SPEZYME CL + PspPro3 TrGA + AkAA + 0.02 kg/MT ds FERMGEN
SPEZYME CL + SumPro2 0325 GAUs/g ds TrGA + 1.950 SSUs/g ds AkAA
SPEZYME CL + SumPro2 TrGA + AkAA + 0.02 kg/MT ds FERMGEN [00184] A 20% w/v yeast solution was prepared by adding 5 grams of Ethanol Red yeast in a 50 mL conical centrifuge tube with the addition of DI water up to 25 mL mark. The yeast solution was mixed for 10 minutes at 150 rpm and each fermentation flask was dosed with 500 μΐ^ of yeast, which yielded a concentration of 0.1% w/w. Each flask was then covered with a rubber stopper with a hole to vent C02. The 20 flasks were incubated at 32°C at 150 rpm for 54 hours. Samples were taken at 6, 22, 29, 48, and 54 hours for ethanol concentrations. A sample was measured into a 2.0 mL centrifuge tube and centrifuged for approximately 3 minutes at 13.2k rpm and prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column.
Fermentation process - Proteases used in fermentation
[00185] The IRE liquefact was at 32.05% ds. The liquefact was thawed at 60°C and then cooled to room temperature, at which point 200 ppm of urea was added to the liquefact. The pH was then adjusted to 4.5 using 6N sulfuric acid. Samples of the initial liquefact were measured into separate 2.0 mL centrifuge tubes and centrifuged for approximately 3 minutes at 13.2k rpm.
After centrifugation, the samples were prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column. A sample of 100.00 grams
(+0.05g) was weighed into 32 separate 250 mL wide-mouthed Erlenmeyer flasks. The dose used for FERMGEN, and proteases are shown in Table 6 below.
Table 6. Dosing of fermentation enzymes
Enzymes and dosages
TrGA + AkAA
TrGA + AkAA + 0.04 kg/MT ds FERMGEN
TrGA + AkAA + 0.00192 mg/g ds SliPro2
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds SliPro2
TrGA + AkAA + 0.00192 mg/g ds SruProl
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds SruProl
TrGA + AkAA + 0.00192 mg/g ds SumPro2
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds SumPro2
TrGA + AkAA + 0.00192 mg/g ds SumProl Enzymes and dosages
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds SumProl
TrGA + AkAA + 0.00192 mg/g ds AruProl
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds AruProl
TrGA + AkAA + 0.00192 mg/g ds PspPro2
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds PspPro2
TrGA + AkAA + 0.00192 mg/g ds PspPro3
TrGA + AkAA + 0.02 kg/MT ds FERMGEN + 0.00096 mg/g ds PspPro3
[00186] A 20% w/v yeast solution was prepared by adding 5 grams of Ethanol Red yeast in a 50 mL conical centrifuge tube with the addition of DI water up to 25 mL mark. The yeast solution was mixed for 10 minutes at 150 rpm and each fermentation flask was dosed with 500 μΐ^ of yeast, which yielded a concentration of 0.1% w/w. Each flask was then covered with a rubber stopper with a hole to vent C02. The 32 flasks were incubated at 32°C at 150 rpm for 54 hours. Samples were taken at 6, 21, 28, 48, and 54 hours for ethanol concentrations. A sample was measured into a 2.0 mL centrifuge tube and centrifuged for approximately 3 minutes at 13.2k rpm and prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column.
Liquefaction process - Addition of proteases & Fermentation process - Proteases used in liquefaction
[00187] Metallopro teases are neutral pH proteases while SumPro2 is a more acidic pH protease but all are fairly thermostable at 70°C. Corn liquefacts were produced using
SPEZYME® CL with and without proteases. The slurry was performed at 70°C for 30 min followed by jet simulation (boil step) which was followed with secondary liquefaction at 85°C for 120 min. In liquefactions in which proteases were used, the protease was added in the slurry and not in secondary liquefaction; thus, the liquefacts were incubated with protease enzymes for only 30 minutes at 70°C. The SPEZYME® CL alpha-amylase dosage was used so that 10 DEs were achieved at the end of the liquefaction. These liquefacts were then used in SSF using TrGA + AKAA with and without FERMGEN® or other proteases.
[00188] As shown in Table 7 below, an increase in ethanol of 0.33-0.43% v/v was observed (comparing averages) at 54 hours when using AruProl or PspPro2 with SPEZYME® CL in liquefaction compared to the control where only SPEZYME® CL was used. No significant ethanol increase was observed when using SumPro2 with SPEZYME® CL in liquefaction while PspPro3 decreased ethanol levels slightly. Adding FERMGEN® in fermentation further enhanced the ethanol for all the treatments.
Table 7. The final ethanol yield at 54 hr for different liquefaction and SSF treatments.
Figure imgf000046_0001
Fermentation process - Proteases used in fermentation (initial results and repeated results)
[00189] SliPro2, SruProl, SumProl, and SumPro2 proteases are acidic pH proteases and were therefore added during SSF with and with FERMGEN®. In addition, AruProl, PspPro2 and PspPro3 (enzymes used in liquefaction and are considered neutral proteases) were also tested in fermentation. The proteases were again dosed at 0.00192 mg/g ds when added with TrGA + AkAA. When both protease and FERMGEN® were used the dose was 0.00096 mg/g ds metalloprotease + 0.00096 mg/g ds FERMGEN® so that the total dose was equivalent to 0.00192 mg/g ds.
[00190] As shown in Table 8 and 9 below, an increase in ethanol of 0.21% v/v was observed (comparing averages) at 54 hours when using TrGA + AkAA + SumPro2 compared to TrGA + AkAA + FERMGEN® control. SruProl and SumProl decreased ethanol levels slightly compared to both TrGA + AkAA + FERMGEN® controls. Adding FERMGEN® in
fermentation boosted the ethanol for all the treatments. SliPro2, SumPro2, PspPro2 and PspPro3 in combination with FERMGEN® showed 0.38-0.54% v/v increase in ethanol (comparing averages) over the TrGA + AkAA + FERMGEN® control. The fermentations were repeated under the same conditions with these proteases. As shown in the second table below, the same results were confirmed. Table 8. The final ethanol yield at 54 hr for different SSF treatments.
Enzymes Ethanol Yield
Tr+AkAA 15.425
Tr+AkAA+FERMGEN 15.625
Tr+AkAA+SliPro2 15.355
Tr+AkAA+FERMGEN+SliPro2 15.900
Tr+AkAA+SruProl 14.710
Tr+AkAA+FERMGEN+SruPro 1 15.320
Tr+AkAA+SumPro2 15.835
Tr+AkAA+FERMGEN+SumPro2 16.165
Tr+AkAA+SumProl 14.880
Tr+AkAA+FERMGEN+SumPro 1 15.510
Tr+ AkA A+ AruPro 1 15.360
Tr+AkAA+FERMGEN+AruPro 1 15.570
Tr+AkAA+PspPro2 15.320
Tr+AkAA+FERMGEN+PspPro2 15.980
Tr+AkAA+PspPro3 15.470
Tr+AkAA+FERMGEN+PspPro3 16.165
Table 9. The final ethanol yield at 54 hr for different SSF treatmf
Enzymes Ethanol Yield
Tr+AkAA 15.375
Tr+AkAA+FERMGEN 15.615
Tr+AkAA+SliPro2 15.240
Tr+AkAA+FERMGEN+SliPro2 15.835
Tr+AkAA+SumPro2 15.765
Tr+AkAA+FERMGEN+SumPro2 16.155
Tr+AkAA+PspPro2 15.230
Tr+AkAA+FERMGEN+PspPro2 15.850
Tr+AkAA+PspPro3 15.330
Tr+AkAA+FERMGEN+PspPro3 16.320 Example 4
Study of the effect on ethanol production for the metalloproteases during liquefaction step of the dry grind ethanol process for wheat and corn as a substrate
[00191] This experiment was performed to study the effect of metalloprotease addition during the liquefaction unit operation in the dry grind process on the ethanol yield for the wheat and corn as substrate. For this study the wheat flour was mixed with DI water to prepare 30% ds slurry. The corn flour was mixed with DI water to prepare 25% ds slurry. The unadjusted pH of the slurry was at ~pH 6.0 and was left unchanged. For wheat, enzyme solutions containing SPEZYME® CL alpha amylase at 1.5 AAUs/g ds and OPTIMASH® TBG at 0.025kg/MT ds were dispensed in the slurry. For corn, enzyme solutions containing SPEZYME® CL alpha amylase at 2.5 AAUs/g ds was dispensed in the slurry. This slurry was mixed at room temperature to blend the added enzymes. A 35 g aliquot with 4 replications for each treatment was weighed into LABOMAT steel beakers. Following the weighing process the proteases were added as such 1) no protease 2) SliPro2 at 0.05mg/g ds, 3) SumProl at 0.05mg/g ds, 4) PehProl at 0.05mg/g ds and 5) PhuProl at 0.05mg/g ds. The metal beakers were fitted back into the LABOMAT for liquefaction unit operation at 60°C for 45 min followed by 85°C for 90 min with clockwise and counter-clockwise constant mixing at 60rpm.
[00192] After the liquefaction the liquefied mash for each treatment was mixed together for pH adjustment and fermentation preparation. The pH was adjusted to pH 4.5 using 4N sulfuric acid. ADY at 3.57 mg/g ds, urea at 600 ppm and GA at 0.325 GAUs /g ds were added to each flask. A 58 g of slurry for wheat and 46.5 g of slurry for corn was thereafter transferred to 125 ml flask for fermentation. The flasks were incubated at 32°C for 54 hrs. The samples were drawn at regular intervals for ethanol measurements.
[00193] The ethanol data from the table below shows that for the wheat fermentation the metalloprotease addition during liquefaction showed significant effect on the ethanol production rate around 22 hour compared to the control but did not affect the final ethanol concentrations. The ethanol data from the Tables 10 and 11 below shows that for the corn fermentation the metalloprotease addition during liquefaction showed significant effect on the ethanol production rate around 22 hours for the corn slurry treated with metalloproteases but did not affect the final ethanol concentrations. Table 10. Effect of metallopro teases addition during liquefaction on the ethanol yield during fermentation of wheat substrate
Figure imgf000049_0001
Table 11. Effect of metalloproteases addition during liquefaction on the ethanol yield during fermentation of corn substrate
Figure imgf000049_0002
[00194] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein can be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims

Claims
1. A method for producing a fermentation product from grain, comprising:
a) liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using:
an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase; b) saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product.
2. A method for reducing the viscosity of the grain slurry during a fermentation, comprising:
a) liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using:
an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase; b) saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product, wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
3. The method of claim 2, wherein the viscosity is reduced by about 30%.
4. The method of claims 2 or 3, wherein the viscosity is reduced by about 40%.
5. The method of any one of claim 2 to 4, wherein the viscosity is reduced by about 50%.
6. A method for reducing the foam in the grain slurry during a fermentation, comprising:
a) liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using:
an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase; b) saccharifying and fermenting the slurry using a glucoamylase, a protease and optionally other enzymes and a fermenting organism to produce the fermentation product; wherein the foam in the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
7. The method of claim 6, wherein the foam is reduced by about 30%,.
8. The method of any one of claim 5 to 7, wherein the foam is reduced by about 40%.
9. The method of any one of claim 5 to 8, wherein the foam is reduced by about 50%.
10. A method for reducing the viscosity of the grain slurry during a liquefaction process, comprising:
a) liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 60°C using an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; and
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
11. The method of claim 10, wherein the viscosity is reduced by about 30%.
12. The method of any one of claim 10 or 11, wherein the viscosity is reduced by about 40%.
13. The method of any one of claim 10 to 12, wherein the viscosity is reduced by about 50%.
14. A method for reducing the foam in the grain slurry during a liquefaction process, comprising:
liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 55°C using:
an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; and
wherein the foam in the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
15. The method of claim 14, wherein the foam is reduced by about 30%,.
16. The method of any one of claim 14 or 15, wherein the foam is reduced by about 40%.
17. The method of any one of claim 14 to 16, wherein the foam is reduced by about 50%.
18. A method for reducing the viscosity of the grain slurry during a liquefaction process, comprising:
liquifying the grain slurry at a pH of about 4.0 to about 6.5 at a temperature in the range from about 45°C to about 95°C using:
an alpha amylase, a protease; and optionally a beta-glucanase or glucoamylase or other enzymes; and
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
19. The method of claim 18, wherein the foam is reduced by about 30%,.
20. The method of any one of claim 18 or 19, wherein the foam is reduced by about 40%.
21. The method of any one of claim 18 to 20, wherein the foam is reduced by about 50%.
22. The method of any one of claims above, wherein the protease is AruProl.
23. The method of any one of claims above, wherein the protease is PspPro2.
24. The method of any one of claims above, wherein the protease is SliPro2.
25. The method of any one of claims above, wherein the protease is SumPro2.
26. The method of any one of claims above, wherein the protease is PspPro3.
27. The method of any one of claims above, wherein the protease is PehProl.
28. The method of any one of claims above, wherein the protease is PhuProl.
29. The method of any one of claims above, wherein the protease is SruProl.
30. The method of any one of claims above, wherein the protease is SumProl.
31. The method of any one of claims above, wherein the protease is PehProl.
32. The method of any one of claims above, wherein the protease is FERMGEN.
33. The method of any one of claims above, wherein the protease is FERMGEN and other one or more proteases.
PCT/US2014/068763 2013-12-19 2014-12-05 Proteases in grain processing WO2015094714A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2013/089939 2013-12-19
CN2013089939 2013-12-19

Publications (1)

Publication Number Publication Date
WO2015094714A1 true WO2015094714A1 (en) 2015-06-25

Family

ID=52282877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/068763 WO2015094714A1 (en) 2013-12-19 2014-12-05 Proteases in grain processing

Country Status (1)

Country Link
WO (1) WO2015094714A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3004342A2 (en) * 2013-05-29 2016-04-13 Danisco US Inc. Novel metalloproteases
WO2018136235A1 (en) * 2017-01-17 2018-07-26 Zea10 Llc Process for producing protein concentrate or isolate and cellulosic thermochemical feedstock from brewers spent grains
EP3110833B1 (en) * 2013-05-29 2020-01-08 Danisco US Inc. Novel metalloproteases
CN114045323A (en) * 2021-12-10 2022-02-15 南宁东恒华道生物科技有限责任公司 Method for preparing fish skin and scale collagen peptide powder by multistage enzymolysis process

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002921A2 (en) 1983-01-28 1984-08-02 Cetus Corp Glucoamylase cdna
EP0135138A2 (en) 1983-08-17 1985-03-27 Cpc International Inc. A novel thermostable glucoamylase and method for its production
WO1986001831A1 (en) 1984-09-18 1986-03-27 Michigan Biotechnology Institute Thermostable starch converting enzymes
US4587215A (en) 1984-06-25 1986-05-06 Uop Inc. Highly thermostable amyloglucosidase
USRE32153E (en) 1978-09-01 1986-05-20 Cpc International Inc. Highly thermostable glucoamylaseand process for its production
EP0238023A2 (en) 1986-03-17 1987-09-23 Novo Nordisk A/S Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus
WO1991017243A1 (en) 1990-05-09 1991-11-14 Novo Nordisk A/S A cellulase preparation comprising an endoglucanase enzyme
WO1992000381A1 (en) 1990-06-29 1992-01-09 Novo Nordisk A/S Enzymatic hydrolysis of starch to glucose, using a genetically engineered enzyme
US5422267A (en) 1984-05-22 1995-06-06 Robert R. Yocum Industrial yeast comprising an integrated glucoamylase gene
WO1999028448A1 (en) 1997-11-26 1999-06-10 Novo Nordisk A/S Thermostable glucoamylase
WO1999034011A2 (en) 1997-12-24 1999-07-08 Genencor International, Inc. Method of assaying for a preferred enzyme and/or detergent
WO2000004136A1 (en) 1998-07-15 2000-01-27 Novozymes A/S Glucoamylase variants
US6022725A (en) 1990-12-10 2000-02-08 Genencor International, Inc. Cloning and amplification of the β-glucosidase gene of Trichoderma reesei
US6376450B1 (en) 1998-10-23 2002-04-23 Chanchal Kumar Ghosh Cleaning compositions containing multiply-substituted protease variants
US20060094080A1 (en) 2004-05-27 2006-05-04 Nigel Dunn-Coleman Trichoderma reesei glucoamylase and homologs thereof
WO2006086792A2 (en) * 2005-02-07 2006-08-17 Novozymes North America, Inc. Fermentation product production processes
US20070148288A1 (en) * 2005-12-23 2007-06-28 California Natural Products Long shelf-life Horchata beverage
WO2008023060A1 (en) * 2006-08-25 2008-02-28 Novozymes A/S Fermentation process
WO2011056991A1 (en) * 2009-11-04 2011-05-12 Abengoa Bioenergy New Technologies, Inc. High efficiency ethanol process and high protein feed co-product
WO2011080352A1 (en) * 2010-01-04 2011-07-07 Novozymes A/S Alpha-amylases
US8058033B2 (en) 2007-11-20 2011-11-15 Danisco Us Inc. Glucoamylase variants with altered properties
WO2011153516A2 (en) 2010-06-03 2011-12-08 Mascoma Corporation Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose
WO2012088303A2 (en) * 2010-12-22 2012-06-28 Novozymes North America, Inc. Processes for producing fermentation products

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32153E (en) 1978-09-01 1986-05-20 Cpc International Inc. Highly thermostable glucoamylaseand process for its production
WO1984002921A2 (en) 1983-01-28 1984-08-02 Cetus Corp Glucoamylase cdna
EP0135138A2 (en) 1983-08-17 1985-03-27 Cpc International Inc. A novel thermostable glucoamylase and method for its production
US5422267A (en) 1984-05-22 1995-06-06 Robert R. Yocum Industrial yeast comprising an integrated glucoamylase gene
US4587215A (en) 1984-06-25 1986-05-06 Uop Inc. Highly thermostable amyloglucosidase
WO1986001831A1 (en) 1984-09-18 1986-03-27 Michigan Biotechnology Institute Thermostable starch converting enzymes
EP0238023A2 (en) 1986-03-17 1987-09-23 Novo Nordisk A/S Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus
WO1991017243A1 (en) 1990-05-09 1991-11-14 Novo Nordisk A/S A cellulase preparation comprising an endoglucanase enzyme
WO1992000381A1 (en) 1990-06-29 1992-01-09 Novo Nordisk A/S Enzymatic hydrolysis of starch to glucose, using a genetically engineered enzyme
US6022725A (en) 1990-12-10 2000-02-08 Genencor International, Inc. Cloning and amplification of the β-glucosidase gene of Trichoderma reesei
WO1999028448A1 (en) 1997-11-26 1999-06-10 Novo Nordisk A/S Thermostable glucoamylase
WO1999034011A2 (en) 1997-12-24 1999-07-08 Genencor International, Inc. Method of assaying for a preferred enzyme and/or detergent
WO2000004136A1 (en) 1998-07-15 2000-01-27 Novozymes A/S Glucoamylase variants
US6376450B1 (en) 1998-10-23 2002-04-23 Chanchal Kumar Ghosh Cleaning compositions containing multiply-substituted protease variants
US20070004018A1 (en) 2004-05-27 2007-01-04 Nigel Dunn-Coleman Trichoderma reesei glucoamylase and homologs thereof
US20060094080A1 (en) 2004-05-27 2006-05-04 Nigel Dunn-Coleman Trichoderma reesei glucoamylase and homologs thereof
US20070015266A1 (en) 2004-05-27 2007-01-18 Nigel Dunn-Coleman Trichoderma reesei glucoamylase and homologs thereof
WO2006086792A2 (en) * 2005-02-07 2006-08-17 Novozymes North America, Inc. Fermentation product production processes
US20070148288A1 (en) * 2005-12-23 2007-06-28 California Natural Products Long shelf-life Horchata beverage
WO2008023060A1 (en) * 2006-08-25 2008-02-28 Novozymes A/S Fermentation process
US8058033B2 (en) 2007-11-20 2011-11-15 Danisco Us Inc. Glucoamylase variants with altered properties
WO2011056991A1 (en) * 2009-11-04 2011-05-12 Abengoa Bioenergy New Technologies, Inc. High efficiency ethanol process and high protein feed co-product
WO2011080352A1 (en) * 2010-01-04 2011-07-07 Novozymes A/S Alpha-amylases
WO2011153516A2 (en) 2010-06-03 2011-12-08 Mascoma Corporation Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose
WO2012088303A2 (en) * 2010-12-22 2012-06-28 Novozymes North America, Inc. Processes for producing fermentation products

Non-Patent Citations (25)

* Cited by examiner, † Cited by third party
Title
"FGSC, Catalogue of Strains", 17 January 2007
"MOLECULAR CLONING: A LABORATORY MANUAL", 2001
"THE ALCOHOL TEXTBOOK", 2009, NOTTINGHAM UNIVERSITY PRESS
BOEL ET AL., EMBO J., vol. 3, 1984, pages 1097 - 1102
BOTHAST ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 67, 2005, pages 19 - 25
CAMPBELL ET AL., CURR. GENET., vol. 16, 1989, pages 53 - 56
CAO ET AL., SCIENCE, vol. 9, 2000, pages 991 - 1001
CHEN ET AL., BIOCHEM. J., vol. 301, 1994, pages 75 - 81
CHEN ET AL., PROTO ENG., vol. 8, 1995, pages 575 - 582
CHEN ET AL., PROTO ENG., vol. 9, 1996, pages 499 - 505
DEL MAR, ANAL. BIOCHEM., vol. 99, 1979, pages 316 - 320
FIEROBE ET AL., BIOCHEMISTRY, vol. 35, 1996, pages 8698 - 8704
FOGARTY ET AL., PROGRESS IN INDUSTRIAL MICROBIOLOGY, vol. 15, 1979, pages 112 - 115
HARRISON ET AL., APPLIED ENVIRON. MICROBIOL., vol. 77, 2011, pages 3916 - 22
JOHN ET AL., BIOTECHNOL. ADV., vol. 27, 2009, pages 145 - 52
KALISZ: "Advances in Biochemical Engineering/Biotechnology", article "Microbial Proteinases"
LEI HONGJIE ET AL: "Proteases supplementation to high gravity worts enhances fermentation performance of brewer's yeast", BIOCHEMICAL ENGINEERING JOURNAL, vol. 77, 29 April 2013 (2013-04-29), pages 1 - 6, XP028682154, ISSN: 1369-703X, DOI: 10.1016/J.BEJ.2013.04.016 *
LI ET AL., PROTEIN ENG., vol. 10, 1997, pages 1199 - 1204
LIU ET AL., SHENG WU GONG CHENG XUE BAO, vol. 27, 2011, pages 1049 - 56
LIU ET AL.: "Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization", ACTA BIOCHIM. BIOPHYS. SIN (SHANGHAI, vol. 40, no. 2, 2008, pages 158 - 65, XP002595560, DOI: doi:10.1111/J.1745-7270.2008.00388.X
PAPAGIANN, BIOTECHNOL. ADV., vol. 25, 2007, pages 244 - 63
RAWLINGS ET AL., NUCLEIC ACIDS RES, vol. 40, 2012, pages D343 - D350
RAWLINGS; SALVESSEN: "Handbook of Proteolytic Enzymes", 2013, ELSEVIER PRESS
SAMBROOK ET AL.: "MOLECULAR CLONING: A LABORATORY MANUAL", 1989, COLD SPRING HARBOR
THOMPSON ET AL., NUCLEIC ACIDS RES., vol. 22, 1994, pages 4673 - 4680

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3004342A2 (en) * 2013-05-29 2016-04-13 Danisco US Inc. Novel metalloproteases
EP3110833B1 (en) * 2013-05-29 2020-01-08 Danisco US Inc. Novel metalloproteases
EP3004342B1 (en) * 2013-05-29 2023-01-11 Danisco US Inc. Novel metalloproteases
WO2018136235A1 (en) * 2017-01-17 2018-07-26 Zea10 Llc Process for producing protein concentrate or isolate and cellulosic thermochemical feedstock from brewers spent grains
CN114045323A (en) * 2021-12-10 2022-02-15 南宁东恒华道生物科技有限责任公司 Method for preparing fish skin and scale collagen peptide powder by multistage enzymolysis process
CN114045323B (en) * 2021-12-10 2023-08-08 南宁东恒华道生物科技有限责任公司 Method for preparing fish skin and scale collagen peptide powder by multistage enzymolysis process

Similar Documents

Publication Publication Date Title
EP2297313B1 (en) Variant alpha-amylases from bacillus subtilis and methods of use, thereof
US9365871B2 (en) Method of using α-amylase from Aspergillus clavatus for saccharification
CN105722989B (en) Trehalase in fermentation
US20160010128A1 (en) Method of using alpha-amylase from aspergillus terreus and pullulanase for saccharification
US20150240223A1 (en) Method of using alpha-amylase from talaromyces emersonii for saccharification
US20150232901A1 (en) Method of using alpha-amylase from aspergillus clavatus and isoamylase for saccharification
US20150218606A1 (en) Method of using alpha-amylase from aspergillus clavatus and pullulanase for saccharification
WO2015066669A1 (en) Proteases in corn processing
US20160040202A1 (en) Method of using alpha-amylase from aspergillus fumigatus and pullulanase for saccharification
WO2015094714A1 (en) Proteases in grain processing
WO2015021601A1 (en) Simultanenous liquifaction and malto-saccharification
WO2014099525A1 (en) Paenibacillus curdlanolyticus amylase, and methods of use, thereof
US9765374B2 (en) Method of using α-amylase from Aspergillus fumigatus and isoamylase for saccharification
AU2022202136A1 (en) Trehalase in fermentations
US20150376668A1 (en) Method of using alpha-amylase from aspergillus terreus and isoamylase for saccharification
WO2015066667A1 (en) Proteases in wheat processing
EP3710580A1 (en) Alpha-amylase, composition and method
AU2014342553A1 (en) Trehalase in fermentations
WO2015094809A1 (en) Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14824202

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14824202

Country of ref document: EP

Kind code of ref document: A1